ASTRONOVA, INC., 10-Q filed on 6/6/2025
Quarterly Report
v3.25.1
Cover Page - shares
 3 Months Ended
Apr. 30, 2025
Jun. 04, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Apr. 30, 2025  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Entity Registrant Name AstroNova, Inc.  
Entity Central Index Key 0000008146  
Current Fiscal Year End Date --01-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Trading Symbol ALOT  
Entity Shell Company false  
Entity Small Business true  
Entity Emerging Growth Company false  
Title of 12(b) Security Common Stock  
Security Exchange Name NASDAQ  
Entity Incorporation, State or Country Code RI  
Entity File Number 0-13200  
Document Quarterly Report true  
Document Transition Report false  
Entity Tax Identification Number 05-0318215  
Entity Address, Address Line One 600 East Greenwich Avenue  
Entity Address, City or Town West Warwick  
Entity Address, Postal Zip Code 02893  
Entity Address, State or Province RI  
City Area Code 401  
Local Phone Number 828-4000  
Entity Common Stock, Shares Outstanding   7,596,235
v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
CURRENT ASSETS    
Cash and Cash Equivalents $ 5,353 $ 5,050
Accounts Receivable, net 21,365 21,218
Inventories, net 51,457 47,894
Prepaid Expenses and Other Current Assets 3,006 3,855
Total Current Assets 81,181 78,017
Property, Plant and Equipment, net 17,520 17,639
Identifiable Intangibles, net 23,414 23,519
Goodwill 15,232 14,515
Deferred Tax Assets, net 8,527 8,431
Right of Use Asset 2,763 1,781
Other Assets 1,687 1,693
TOTAL ASSETS 150,324 145,595
CURRENT LIABILITIES    
Accounts Payable 11,383 7,928
Accrued Compensation 4,878 3,745
Other Accrued Expenses 4,165 4,461
Revolving Line of Credit 18,370 20,929
Current Portion of Long-Term Debt 6,041 6,110
Short-Term Debt 327 581
Current Liability—Royalty Obligation 1,233 1,358
Current Liability—Excess Royalty Payment Due 580 691
Deferred Revenue 1,666 543
Total Current Liabilities 48,643 46,346
NON-CURRENT LIABILITIES    
Long-Term Debt, net of current portion 20,002 19,044
Lease Liabilities, net of current portion 2,318 1,535
Grant Deferred Revenue 1,144 1,090
Royalty Obligation, net of current portion 982 1,106
Income Taxes Payable 684 684
Deferred Tax Liabilities 0 40
TOTAL LIABILITIES 73,773 69,845
SHAREHOLDERS' EQUITY    
Preferred Stock, $10 Par Value, Authorized 100,000 shares, None Issued
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 11,800,233 and 10,936,220 shares at April 30, 2025 and January 31, 2025, respectively 550 547
Additional Paid-in Capital 64,569 64,215
Retained Earnings 49,004 49,380
Treasury Stock, at Cost, 3,411,998 and 3,394,942 shares at April 30, 2025 and January 31, 2025, respectively (35,198) (35,043)
Accumulated Other Comprehensive Loss, net of tax (2,374) (3,349)
TOTAL SHAREHOLDERS' EQUITY 76,551 75,750
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 150,324 $ 145,595
v3.25.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Apr. 30, 2025
Jan. 31, 2025
Statement of Financial Position [Abstract]    
Preferred Stock, Par Value $ 10 $ 10
Preferred Stock, Shares Authorized 100,000 100,000
Preferred Stock, Shares Issued 0 0
Common Stock, Par Value $ 0.05 $ 0.05
Common Stock, Shares Authorized 13,000,000 13,000,000
Common Stock, Shares Issued 11,800,233 10,936,220
Treasury Stock, Shares 3,411,998 3,394,942
v3.25.1
Condensed Consolidated Statements of Income (Loss) - USD ($)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Income Statement [Abstract]    
Revenue $ 37,708,000 $ 32,961,000 [1]
Cost of Revenue 25,056,000 20,989,000
Gross Profit 12,652,000 11,972,000
Operating Expenses:    
Selling and Marketing 5,554,000 5,656,000
Research and Development 1,543,000 1,603,000
General and Administrative 4,984,000 3,367,000
Total Operating Expenses 12,081,000 10,626,000
Operating Income 571,000 1,346,000
Other Income (Expense):    
Interest Expense (897,000) (482,000)
Other Income/(Expense), net [2] 25,000 (117,000)
Total Other Income (Expense) (872,000) (599,000)
Income (Loss) Before Income Taxes (301,000) 747,000
Income Tax Provision (Benefit) 75,000 (434,000)
Net Income (Loss) $ (376,000) $ 1,181,000
Net Income (Loss) per Common Share-Basic $ (0.05) $ 0.16
Net Income (Loss) per Common Share-Diluted $ (0.05) $ 0.15
Weighted Average Number of Common Shares Outstanding—Basic 7,559,704 7,459,394
Weighted Average Number of Common Shares Outstanding—Diluted 7,559,704 7,628,025
[1] Certain amounts have been reclassified to conform to the current year's presentation.
[2] Includes gain/(loss) on foreign exchange and other miscellaneous income/(expense) not allocated to the reporting segments.
v3.25.1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Statement of Comprehensive Income [Abstract]    
Net Income (Loss) $ (376) $ 1,181
Other Comprehensive Income (Loss), net of taxes:    
Foreign Currency Translation Adjustments 975 (197)
Other Comprehensive Income (Loss) 975 (197)
Comprehensive Income $ 599 $ 984
v3.25.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance at Jan. 31, 2024 $ 90,282 $ 541 $ 62,684 $ 63,869 $ (34,593) $ (2,219)
Beginning Balance, Shares at Jan. 31, 2024   10,812,137        
Share-Based Compensation 325   325      
Employee Stock Purchase Plan 30   30      
Employee Stock Purchase Plan, Shares   2,246        
Employee Option Exercises 18   18      
Employee Option Exercises, Shares   2,809        
Restricted Stock Awards Vested (432) $ 4 (4)   (432)  
Restricted Stock Awards Vested, Shares   78,077        
Net Income (Loss) 1,181     1,181    
Foreign Currency Translation Adjustments (197)         (197)
Ending Balance at Apr. 27, 2024 91,207 $ 545 63,053 65,050 (35,025) (2,416)
Ending Balance, Shares at Apr. 27, 2024   10,895,269        
Beginning Balance at Jan. 31, 2025 75,750 $ 547 64,215 49,380 (35,043) (3,349)
Beginning Balance, Shares at Jan. 31, 2025   10,936,220        
Share-Based Compensation 306   306      
Employee Stock Purchase Plan $ 51   51      
Employee Stock Purchase Plan, Shares   6,463        
Employee Option Exercises, Shares 0          
Restricted Stock Awards Vested $ (155) $ 3 (3)   (155)  
Restricted Stock Awards Vested, Shares   65,550        
Net Income (Loss) (376)     (376)    
Foreign Currency Translation Adjustments 975         975
Ending Balance at Apr. 30, 2025 $ 76,551 $ 550 $ 64,569 $ 49,004 $ (35,198) $ (2,374)
Ending Balance, Shares at Apr. 30, 2025   11,008,233        
v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Cash Flows from Operating Activities:    
Net Income (Loss) $ (376) $ 1,181
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:    
Depreciation and Amortization 1,290 911
Grant Income charged to Depreciation 56 0
Amortization of Debt Issuance Costs 8 6
Share-Based Compensation 306 325
Deferred Income Tax Provision (52) 0
Changes in Assets and Liabilities:    
Accounts Receivable 210 5,130
Inventories (2,704) 1,117
Income Taxes 172 (532)
Accounts Payable and Accrued Expenses 3,622 (1,213)
Deferred Revenue 1,041 (183)
Other 822 162
Net Cash Provided by Operating Activities 4,395 6,904
Cash Flows from Investing Activities:    
Purchases of Property, Plant and Equipment (60) (492)
Net Cash Used by Investing Activities (60) (492)
Cash Flows from Financing Activities:    
Net Cash Proceeds from Employee Stock Option Plans 0 18
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan 51 30
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock (155) (432)
Repayments under Revolving Credit Facility (2,872) (5,500)
Payment of Minimum Guarantee Royalty Obligation (428) (375)
Principal Payments of Long-Term Debt (826) (710)
Net Cash Used for Financing Activities (4,230) (6,969)
Effect of Exchange Rate Changes on Cash and Cash Equivalents 198 20
Net (Decrease) Increase in Cash and Cash Equivalents 303 (537)
Cash and Cash Equivalents, Beginning of Period 5,050 4,527
Cash and Cash Equivalents, End of Period 5,353 3,990
Supplemental Information:    
Interest 770 409
Income Taxes, net of refunds (100) 93
Non-Cash Transactions:    
Operating Lease Obtained in Exchange for Operating Lease Liabilities $ 936 $ 358
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Pay vs Performance Disclosure    
Net Income (Loss) $ (376) $ 1,181
v3.25.1
Insider Trading Arrangements
 3 Months Ended
Apr. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Business and Basis of Presentation
 3 Months Ended
Apr. 30, 2025
Business and Basis Of Presentation [Abstract]  
Business and Basis of Presentation

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries.

Our business consists of two segments, Product Identification (“Product ID”) and Aerospace (formally known as Test & Measurement).

Effective February 1, 2025, we changed the name of our Test & Measurement segment to “Aerospace” to better reflect the end markets we serve in that segment. The segment name change did not result in any change to the composition of our reportable segments and, therefore, did not result in any changes to our historical segment results.

Our Product ID segment includes tabletop printers, professional label printers, direct to package/overprint printers, mail and sheet/flat pack printers and our most recently launched flexible packaging printers. The Aerospace segment consists of our line of Aerospace products, including flight deck printers, networking hardware, and related accessories as well as data acquisition systems sold under the AstroNova® brand name.

On May 4, 2024, we entered into an agreement to acquire MTEX New Solution, S.A., (“MTEX”), a Portugal-based manufacturer of digital printing equipment that addresses a wide variety of markets and applications including wide format high-volume package printing, labeling, flexible package printing and more. Through this acquisition we acquired innovative print engine technology and expanded our addressable market with larger print machines for mid- to high- volume print applications. The new print engine technology enables lower total cost of ownership for our customers, which we expect to provide us with a competitive advantage in the industry and the opportunity for higher margins on recurring revenue. We reported MTEX as a part of our Product ID segment as of May 6, 2024, the closing date of this acquisition. Refer to Note 3, “Acquisition” for further details. Subsequent to the acquisition, MTEX has been fully integrated into the Product ID segment and no longer operates as an independent business entity.

Customers of our Product ID segment include brand owners, professional printing houses and small print shops, corrugated box and paper bag makers, paper packaging converters and co-packers, original equipment manufacturers (“OEMs”) and channels active in direct mail and transactional print. Product ID products sold under the QuickLabel, TrojanLabel, GetLabels and AstroJet brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding, and labeling solutions to a wide array of industries. The Product ID segment offers a variety of digital color label tabletop printers and light commercial label printers, direct-to-package printers, high-volume presses, and specialty OEMs printing systems. We expanded our product offerings with the May 2024 MTEX acquisition to include mid-to-high volume direct-to-package printers, flexible packaging printers, and label printers primarily targeting the industrial and commercial printing segments. Products manufactured by our Astro Machine facility also include a variety of label printers, mail and flat-pack printers and packaging printing, and related processing and handling equipment. Hardware sales are approximately 20% of Product ID segment revenue. The Product ID segment also offers a wide range of printer supplies, repair parts and service. The supplies include labels, tags, ink and toner, allowing customers to mark, track, protect and enhance the appearance of their products. Recurring supplies, parts and service revenue is approximately 80% of segment revenue.

Our Product ID products are sold by direct field salespersons and independent dealers and representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in Product ID products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Portugal, Singapore, and the United Kingdom staffed by our own employees and dedicated third party contractors. Additionally, we utilize over 125 independent dealers and representatives selling and marketing our products in approximately 100 countries.

In the Aerospace segment, we have a long history of using our technologies to provide networking systems and high-resolution flight deck and cabin printers for the aerospace market. We also provide the repair parts, service, specialty paper and other supplies for our aerospace customers. Hardware comprises approximately 55% of segment revenue and the remaining 45% is recurring sales of supplies, parts and service. Customers include defense industry prime contractors, aircraft OEMs and commercial airlines. In addition, the Aerospace segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed, analyzed, stored and presented in various visual output formats. Customers for these solutions include NASA, and defense industry prime contractors, as well as other entities that utilize these solutions in high precision applications for power, rail, and

industrial manufacturing. Our Aerospace products are predominantly sold directly and through a limited number of independent representatives.

Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended January 31, 2025.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, including those that require consideration of forecasted financial information using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, allowances for doubtful accounts, inventory valuation, income taxes, valuation of long-lived assets, intangible assets and goodwill, share-based compensation, and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates.

Beginning with the first quarter of our fiscal year ending January 31, 2026, we have adjusted our fiscal quarters to end on April 30, July 31, October 31 and January 31. Prior year periods have not been recast to reflect this change.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year’s financial statements have been reclassified to conform to the current year’s presentation.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

v3.25.1
Summary of Significant Accounting Policies Update
 3 Months Ended
Apr. 30, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Update

Note 2 – Summary of Significant Accounting Policies Update

The accounting policies used in preparing the condensed consolidated financial statements in this Form 10-Q are the same as those used in preparing our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2025.

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the Financial Accounting Standards Board ( “FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” ASU 2024-03 enhances expense disclosures on both an annual and interim basis by requiring public entities to disclose additional information about specific expense categories in the notes to the consolidated financial statements. This ASU requires disclosure in tabular format of purchases of inventory, employee compensation, depreciation, intangible asset amortization and depletion, as applicable, for each income statement line item that contains those expenses. Specific expenses, gains and losses that are already disclosed under existing US GAAP are also required to be included in the disaggregated income statement expense line-item disclosures, and any remaining amounts will need to be described quantitatively. Additionally, ASU 2024-03 requires disclosure of the total amount of selling expenses and the entity’s definition of selling expenses. ASU 2024-03 is effective for the first annual disclosure period beginning after December 15, 2026 and for the interim periods subsequent to that, with early adoption permitted. The amendment should be applied prospectively; however, retrospective application is permitted. We are currently evaluating the new disclosure requirements of ASU 2024-04 and do not expect the adoption of this guidance to have a material impact on our consolidated financial statements or disclosures.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” to enhance the transparency and decision usefulness of income tax disclosures primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 modifies the requirement for income tax disclosures to include (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic

and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact and related disclosures required as a result of adopting this new guidance within our Annual Report on Form 10-K for the year ended January 31, 2026 and subsequent annual reports.

No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

v3.25.1
Acquisition
 3 Months Ended
Apr. 30, 2025
Business Combinations [Abstract]  
Acquisition

Note 3 – Acquisition

MTEX

Background

On May 4, 2024, AstroNova, along with its wholly-owned Portuguese subsidiary, AstroNova Portugal, Unipessoal, Lda (the “Purchaser”) entered into a Share Purchase Agreement (the “Purchase Agreement”) with Effort Premier Solutions Lda., a private limited company incorporated under the laws of Portugal (the “Seller”) and Elói Serafim Alves Ferreira, as the “Guarantor.”

In accordance with the terms and subject to the conditions set forth in the Purchase Agreement, the Purchaser acquired from the Seller, 100% of the issued and outstanding share capital of MTEX. The closing date for the acquisition was May 6, 2024. This transaction was a business combination and accounted for using the acquisition method as prescribed by ASC 805.

The purchase price for this acquisition consisted of EUR 17,268,345 (approximately $18.7 million) paid by the Purchaser to the Seller on the closing date, and up to an additional EUR 731,655 (approximately $0.8 million) retained by the Purchaser to secure certain indemnification obligations of the Seller to be released by the Purchaser subject to resolution of such obligations.

Upon the closing of the transaction, MTEX became a wholly owned indirect subsidiary of AstroNova, Inc. It has since been fully integrated into the organization.

 

Purchase Price Allocation

A summary of the fair value of the consideration transferred as of the acquisition closing date is presented in the table below:

(In thousands)

 

Preliminary Estimate

 

 

Measurement Period Adjustment

 

 

Final

 

Cash Paid at Closing

 

$

18,732

 

 

$

(1

)

 

$

18,731

 

Holdback Amount

 

 

742

 

 

 

—

 

 

 

742

 

Fair Value of the Earnout

 

 

1,619

 

 

 

(1,619

)

 

 

—

 

Total Purchase Price

 

$

21,093

 

 

$

(1,620

)

 

$

19,473

 

 

In accordance with the terms of the Purchase Agreement, the Seller may have been entitled to additional contingent consideration of potential earn out payments if specified revenue targets were achieved by MTEX for the three calendar year periods ending after the closing date. The approach to valuing the initial contingent consideration relating to the earn-out requires the use of unobservable factors such as projected revenues over the term of the earn-out periods, discounted for the period over which the initial contingent consideration is measured, and relevant volatility rates. Based upon these assumptions, the earn-out contingent consideration was valued using an option pricing model, which resulted in the estimated fair value being reduced to zero as of the acquisition closing date.

Since the initial preliminary estimates reported in the second quarter of fiscal 2024, we have adjusted certain amounts for the fair value of the assets acquired and liabilities assumed as a result of obtaining additional information that allowed us to determine the final purchase price allocation. Measurement period adjustments were recognized in the reporting period in which the adjustments were determined and calculated as if the accounting had been completed at the acquisition date. As of the end of the first quarter of fiscal 2026, we completed our final fair value determination of the assets acquired and liabilities assumed.

The following table sets forth the final purchase price allocation of the MTEX acquisition for the estimated fair value of the net assets acquired and liabilities assumed as of May 6, 2024:

 

(In thousands)

 

Preliminary Estimate

 

 

Measurement Period Adjustment

 

 

Final Purchase Price Allocation

 

Cash

 

$

364

 

 

$

—

 

 

$

364

 

Accounts Receivable

 

 

3,989

 

 

 

(2,777

)

 

 

1,212

 

Inventory

 

 

3,807

 

 

 

(200

)

 

 

3,607

 

Prepaid Expenses and Other Current Assets

 

 

301

 

 

 

—

 

 

 

301

 

Property, Plant and Equipment

 

 

4,802

 

 

 

—

 

 

 

4,802

 

Other Long-Term Assets

 

 

5,154

 

 

 

1,054

 

 

 

6,208

 

Identifiable Intangible Assets

 

 

9,556

 

 

 

(2,017

)

 

 

7,539

 

Goodwill

 

 

10,629

 

 

 

3,650

 

 

 

14,279

 

Accounts Payable and Other Current Liabilities

 

 

(4,225

)

 

 

(1,870

)

 

 

(6,095

)

Debt Assumed

 

 

(7,918

)

 

 

—

 

 

 

(7,918

)

Other Long-Term Liabilities

 

 

(5,366

)

 

 

540

 

 

 

(4,826

)

Total Purchase Price

 

$

21,093

 

 

$

(1,620

)

 

$

19,473

 

The following table reflects the preliminary fair value of the acquired identifiable intangible assets and related estimated useful lives:

(In thousands)

 

Fair
Value

 

 

Measurement Period Adjustment

 

 

Final Fair Value

 

 

Useful Life
(years)

 

Customer Relations

 

$

8,786

 

 

$

(6,183

)

 

$

2,603

 

 

 

10

 

Internally Developed Technology

 

 

488

 

 

 

4,231

 

 

 

4,719

 

 

 

6

 

Trademarks/Tradenames

 

 

282

 

 

 

(65

)

 

 

217

 

 

 

3

 

Total

 

$

9,556

 

 

$

(2,017

)

 

$

7,539

 

 

 

 

The customer relations intangible asset represents the relationships that will be maintained with certain historical customers of MTEX. The trademark/tradename intangible assets reflect the industry reputation of the MTEX name and the registered trademarks held by MTEX for the use of several marks and logos. The internally developed technology intangible asset represents software used to collect a wide range of data on each piece of equipment and the ability to monitor customer ink usage and troubleshoot issues with customers.

The fair value of the customer relations intangible asset acquired was estimated by applying the income approach using the Multi-Period Excess Earning Method. This fair value measurement is based on significant inputs that are not observable in the market and therefore represents a Level 3 measurement as defined in ASC 820, “Fair Value Measurement”. The fair value determined under this approach is a function of (i) future revenues expected to be generated by these assets and the profitability of the assets, (ii) identification of the contribution of other tangible and intangible assets to the cash flows generated by these asset to apply an appropriate capital charge against the cash flow, and (iii) a discount rate of 15.5% used to calculate the present value of the stream of anticipated cash flows. The fair value of the trademark intangible asset acquired was estimated by applying the income approach using the “relief-from-royalty” method. The value under the relief-from-royalty method is a function of (i) the concluded royalty rate of 0.75%, (ii) projected revenues generated by product sales under the asset being valued, and (iii) a discount rate of 15.5%. The fair value of the internally developed technology intangible asset acquired was estimated by applying the cost approach, which takes into consideration the internal development costs of the technology and a hypothetical developer’s profit margin to build the software, the opportunity costs the buyer avoids by not having to reproduce this asset and any duplicative or unproductive efforts, as well as functional obsolescence of the technology.

The purchased goodwill of $14.3 million, which is not deductible for tax purposes, represents the excess of the purchase price over the estimated fair value assigned to the tangible and identifiable intangible assets acquired and liabilities assumed from MTEX. The goodwill recognized under ASC 805 is attributable to the expected earnings potential of the business, synergies which are expected to enhance and expand our overall product portfolio, opportunities in new and existing markets, and MTEX's assembled workforce. The carrying amount of the goodwill was allocated to the Product ID segment. In the fourth quarter of fiscal 2025, we recognized a $13.4 million impairment charge related to the MTEX goodwill.

During the first quarter of the current year, we incurred an additional $0.3 million of acquisition-related costs which were included in general and administrative expenses in our condensed consolidated statements of income for the three months ended April 30, 2025. Total acquisition-related costs through April 30, 2025 were $1.5 million, including $1.2 million recognized in fiscal 2025.

The amounts of revenue and earnings before taxes attributable to MTEX and included in our consolidated statements of income for the three months ended April 30, 2025 were as follows:

 

 

 

 

 

(In thousands)

 

 

 

 

Revenue

 

$

1,402

 

(1)

Gross Profit

 

 

119

 

 

Operating Expenses:

 

 

 

 

   Selling Expenses

 

 

630

 

 

   Research and Development Expenses

 

 

171

 

 

   General and Administrative Expenses

 

 

236

 

 

      Total Operating Expenses

 

$

1,037

 

 

Operating Loss

 

 

(918

)

 

Other Expenses

 

 

(138

)

 

Earnings (Loss) before Taxes

 

$

(1,056

)

 

(1) Include $727,000 of MTEX revenue related to sales that were sold to third parties via intercompany sales.

*MTEX was acquired on May 6, 2024, and therefore no results are included in AstroNova consolidated income (loss) for the period ended April 27, 2024.

MTEX no longer operates as an independent business, but rather our manufacturing operation in Portugal is treated as a cost center. The majority of MTEX sales are through intercompany operations. MTEX financial results are reported as part of the Product ID segment. Pro forma results as if the acquisition was closed on February 1, 2024 are not provided, as disclosure of such amounts was impractical to determine.
v3.25.1
Revenue Recognition
 3 Months Ended
Apr. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Recognition

Note 4 – Revenue Recognition

We derive revenue from (i) the sale of hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems, and airborne printers and networking hardware used in the flight deck and cabin of military, commercial and business aircraft, (ii) the sale of related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:

 

 

Three Months Ended

 

 

(In thousands)

 

April 30, 2025

 

 

April 27, 2024*

 

 

United States

 

$

22,671

 

 

$

19,564

 

 

Europe

 

 

9,886

 

 

 

8,970

 

 

Canada

 

 

1,506

 

 

 

1,759

 

 

Asia

 

 

1,960

 

 

 

1,186

 

 

Central and South America

 

 

1,343

 

 

 

1,198

 

 

Other

 

 

342

 

 

 

284

 

 

Total Revenue

 

$

37,708

 

 

$

32,961

 

 

*Certain amounts have been reclassified to conform to the current year's presentation.

Major product types:

 

 

Three Months Ended

 

 

(In thousands)

 

April 30, 2025

 

 

April 27, 2024

 

 

Hardware

 

$

11,295

 

 

$

8,875

 

 

Supplies

 

 

21,080

 

 

 

18,633

 

 

Service and Other

 

 

5,333

 

 

 

5,453

 

 

Total Revenue

 

$

37,708

 

 

$

32,961

 

 

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.

Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were $565,000 and $543,000 at April 30, 2025 and January 31, 2025, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. The increase in the deferred revenue balance during the three months ended April 30, 2025 is due to cash payments received in advance of satisfying performance obligations in excess of revenue recognized during the current period, including $146,000 of revenue recognized that was included in the deferred revenue balance at January 31, 2025.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized over the remaining useful life of these contracts, which we currently estimate to be approximately 16 years as of April 30, 2025. We also recognize an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. The balance of these contract assets at January 31, 2025 was $1.5 million. During the three months ended April 30, 2025 and April 27, 2024, we amortized contract costs of $23,000 and $19,000, respectively. The balance of deferred incremental direct costs net of accumulated amortization at April 30, 2025 was $1.5 million, of which $0.1 million is reported in other current assets, and $1.4 million is reported in other assets in the accompanying condensed consolidated balance sheet.

v3.25.1
Net Income (Loss) Per Common Share
 3 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Net Income (Loss) Per Common Share

Note 5 – Net Income (Loss) Per Common Share

Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period. Diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income (loss) per share is as follows:

 

 

Three Months Ended

 

 

 

April 30, 2025

 

 

April 27, 2024

 

 

Weighted Average Common Shares Outstanding – Basic

 

 

7,559,704

 

 

 

7,459,394

 

 

Effect of Dilutive Options, Restricted Stock Awards and
   Restricted Stock Units

 

 

—

 

(1)

 

168,631

 

 

Weighted Average Common Shares Outstanding – Diluted

 

 

7,559,704

 

 

 

7,628,025

 

 

(1)For the three months ended April 30, 2025, we had weighted average common stock equivalent shares outstanding of 67,066 that could potentially dilute earnings per share in future periods. These shares were excluded from the computation of diluted earnings per share because their effect would have been anti-dilutive given the net loss during the period.

For the three months ended April 30, 2025, and April 27, 2024, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of 451,199 and 181,999, respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

v3.25.1
Intangible Assets
 3 Months Ended
Apr. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

Note 6 – Intangible Assets

Intangible assets are as follows:

 

 

April 30, 2025

 

 

January 31, 2025

 

(In thousands)

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization

 

 

Currency
Translation
Adjustment

 

 

Net
Carrying
Amount

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization

 

 

Currency
Translation
Adjustment

 

 

Net
Carrying
Amount

 

RITEC:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
       Relationships

 

$

2,830

 

 

$

(1,772

)

 

$

—

 

 

$

1,058

 

 

$

2,830

 

 

$

(1,755

)

 

$

—

 

 

$

1,075

 

TrojanLabel:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Distributor Relations

 

937

 

 

 

(798

)

 

 

33

 

 

 

172

 

 

937

 

 

 

(774

)

 

 

16

 

 

 

179

 

Honeywell:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
       Relationships

 

 

27,773

 

 

 

(13,878

)

 

 

—

 

 

 

13,895

 

 

 

27,773

 

 

 

(13,661

)

 

 

—

 

 

 

14,112

 

Astro Machine:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
      Relationships

 

 

3,060

 

 

 

(1,683

)

 

 

—

 

 

 

1,377

 

 

 

3,060

 

 

 

(1,530

)

 

 

—

 

 

 

1,530

 

   Trademarks

 

420

 

 

 

(231

)

 

 

—

 

 

 

189

 

 

420

 

 

 

(210

)

 

 

—

 

 

 

210

 

MTEX:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
      Relationships

 

 

2,603

 

 

 

(259

)

 

 

109

 

 

 

2,453

 

 

 

2,603

 

 

 

(194

)

 

 

(104

)

 

 

2,305

 

   Internally Developed Technology

 

 

4,719

 

 

 

(782

)

 

 

182

 

 

 

4,119

 

 

 

4,719

 

 

 

(586

)

 

 

(181

)

 

 

3,952

 

   Trademarks

 

 

217

 

 

 

(72

)

 

 

6

 

 

 

151

 

 

 

217

 

 

 

(54

)

 

 

(7

)

 

 

156

 

Intangible Assets, net

 

$

42,559

 

 

$

(19,475

)

 

$

330

 

 

$

23,414

 

 

$

42,559

 

 

$

(18,764

)

 

$

(276

)

 

$

23,519

 

There were no impairments to intangible assets during the three months ended April 30, 2025 and April 27, 2024.

With respect to the acquired intangible assets included in the table above, amortization expense of $0.7 million and $0.4 million has been included in the condensed consolidated statements of income for the three months ended April 30, 2025, and April 27, 2024, respectively.

 

Estimated amortization expense for the next five fiscal years is as follows:

 

(In thousands)

 

Remaining
2026

 

 

2027

 

 

2028

 

 

2029

 

 

2030

 

Estimated amortization expense

 

$

2,131

 

 

$

2,841

 

 

$

2,342

 

 

$

1,976

 

 

$

1,976

 
v3.25.1
Inventories
 3 Months Ended
Apr. 30, 2025
Inventory Disclosure [Abstract]  
Inventories

Note 7 – Inventories

Inventories are stated at the lower of cost (standard and average methods) or net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:

 

(In thousands)

 

April 30, 2025

 

 

January 31, 2025

 

Materials and Supplies

 

$

36,153

 

 

$

35,181

 

Work-In-Process

 

 

2,843

 

 

 

2,559

 

Finished Goods

 

 

22,306

 

 

 

19,879

 

 

 

61,302

 

 

 

57,619

 

Inventory Reserve

 

 

(9,845

)

 

 

(9,725

)

 

$

51,457

 

 

$

47,894

 
v3.25.1
Property, Plant and Equipment
 3 Months Ended
Apr. 30, 2025
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment

Note 8 – Property, Plant and Equipment

Property, plant and equipment consist of the following:

 

(In thousands)

 

April 30, 2025

 

 

January 31, 2025

 

Land and Land Improvements

 

$

2,304

 

 

$

2,304

 

Buildings and Leasehold Improvements

 

 

15,184

 

 

 

15,116

 

Machinery and Equipment

 

 

30,997

 

 

 

30,403

 

Computer Equipment and Software

 

 

14,565

 

 

 

14,538

 

Gross Property, Plant and Equipment

 

 

63,050

 

 

 

62,361

 

Accumulated Depreciation

 

 

(45,530

)

 

 

(44,722

)

Net Property Plant and Equipment

 

$

17,520

 

 

$

17,639

 

Depreciation expense on property, plant and equipment was $0.6 million and $0.4 million for the three months ended April 30, 2025 and April 27, 2024, respectively.

v3.25.1
Credit Agreement and Long-Term Debt
 3 Months Ended
Apr. 30, 2025
Debt Disclosure [Abstract]  
Credit Agreement and Long-Term Debt

Note 9 – Credit Agreement and Long-Term Debt

In connection with our purchase of MTEX, on May 6, 2024, we entered a Third Amendment to Amended and Restated Credit Agreement (the “Third Amendment”) with Bank of America, N.A., as lender (the “Lender”). The Third Amendment amended the Amended and Restated Credit Agreement dated as of July 30, 2020, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of March 24, 2021, the LIBOR Transition Amendment, dated as of December 14, 2021, the Second Amendment to Amended and Restated Credit Agreement dated as of August 4, 2022, and the Joinder Agreement relating to our subsidiary Astro Machine Corporation (“Astro Machine”) dated as of August 26, 2022 (as so amended, the “Credit Agreement”; the Credit Agreement as amended by the Amendment, the “Amended Credit Agreement”), between AstroNova, Inc. as the borrower, Astro Machine as a guarantor, and the Lender.

The Amended Credit Agreement provides for (i) a new term loan to AstroNova, Inc. in the principal amount of EUR 14.0 million (the “Term A-2 Loan”), which term loan is in addition to the existing term loan (the “Term Loan”) outstanding under the Credit Agreement in the principal amount of approximately $12.3 million as of the effective date of the Third Amendment, and (ii) an increase in the aggregate principal amount of the revolving credit facility available to AstroNova, Inc. from $25.0 million to $30.0 million until January 31, 2025, upon and after which the aggregate principal amount of the revolving credit facility reduced to $25.0 million. At the closing of the Third Amendment, we borrowed the entire EUR 14.0 million Term A-2 Loan, EUR 3.0 million under the revolving credit facility and a US dollar amount under the revolving credit facility that was converted to Euros to satisfy the entire purchase price payable on the closing date pursuant to the Purchase Agreement. The revolving credit facility may otherwise be used for general corporate purposes.

On March 20, 2025, we entered into a Fourth Amendment to Amended and Restated Credit Agreement (the “Fourth Amendment”) with Bank of America, which further amended the Amended Credit Agreement (as so amended, the “Further Amended Credit Agreement”).

The Further Amended Credit Agreement modified the remaining quarterly installments in which the outstanding balance of the Term Loan must be paid. The outstanding principal balance of the Term Loan as of the effective date of the Fourth Amendment was $9.5 million. Under the Further Amended Credit Agreement, such remaining quarterly installments must be paid on the last day of each of our fiscal quarters through April 30, 2027 in the principal amount of (i) in the case of the installments for the fiscal quarters ending April 30, 2025 through January 31, 2026, $325,000 each, (ii) in the case of the installments for the fiscal quarters ending April 30, 2026 through January 31, 2027, $725,000 each, and (iii) in the case of the installment for the fiscal quarter ending April 30, 2027, $950,000; the entire then-outstanding principal balance of the Term Loan is required to be paid on August 4, 2027. We continue to have the right to voluntarily prepay the Term Loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable).

The remaining repayment installments of the Term A-2 Loan were not modified by the Fourth Amendment; the outstanding principal balance of the Term A-2 Loan as of the effective date of the Fourth Amendment was EUR 12,250,000 million. The Further Amended Credit Agreement requires that the remaining balance of the Term A-2 Loan be paid in quarterly installments on the last day of each of our fiscal quarters through April 30, 2027 in the principal amount of EUR 583,333 each, and the entire then-remaining principal balance of the Term A-2 Loan is required to be paid on August 4, 2027. We continue to have the right to voluntarily prepay the Term A-2 Loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable).

The amount and availability and repayment terms of the existing $25.0 million revolving credit facility available to the Company under the Further Amended Credit Agreement were not modified by the Fourth Amendment; the outstanding principal balance under the revolving credit facility as of the effective date of the Fourth Amendment was $21.7 million. We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than August 4, 2027, and any outstanding revolving loans thereunder will be due and payable in full, and the revolving credit facility will terminate, on such date. We may reduce or terminate the revolving credit facility at any time, subject to certain thresholds and conditions, without premium or penalty.

The loans under the Further Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from net cash proceeds from certain dispositions of property, certain issuances of equity, certain issuances of additional debt and certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to our continued compliance with the Further Amended Credit Agreement. No amount of the Term Loan or the Term A-2 Loan that is repaid may be reborrowed.

The Further Amended Credit Agreement modified the applicable interest rate margins payable with respect to the Term Loan, the Term A-2 Loan and the revolving credit facility loans and modified the commitment fee payable with respect to the undrawn portion of the revolving credit facility. Under the Further Amended Credit Agreement, the Term Loan and revolving credit facility loans bear interest at a rate per annum equal to, at the Company’s option, either (a) the Term SOFR rate as defined in the Further Amended Credit Agreement (or, in the case of revolving credit loans denominated in Euros or another currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.85% based our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate (iii) the Term SOFR Rate plus 1.00%, or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.85% based on our consolidated leverage ratio. Under the Further Amended Credit Agreement, the Term A-2 Loan bears interest at a rate per annum equal to the EURIBOR rate as defined in the Further Amended Credit Agreement, plus a margin that varies within a range of 1.60% to 2.85% based on our consolidated leverage ratio. Under the Further Amended Credit Agreement, the commitment fee that we are required to pay on the undrawn portion of the revolving credit facility under the Further Amended Credit Agreement varies within a range of 0.15% and 0.40% based on our consolidated leverage ratio.

We must comply with various customary financial and non-financial covenants under the Further Amended Credit Agreement, certain provisions of which covenants were modified by the Fourth Amendment. The financial covenants under the Further Amended Credit Agreement consist of a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio that is tested commencing with the measurement period ending with the fiscal quarter ending January 31, 2026, and a minimum interim consolidated fixed charge coverage ratio that is tested for certain measurement periods ending April 30, 2025, July 31, 2025 and October 31, 2025; the interim minimum consolidated fixed charge coverage ratio was added by the Fourth Amendment, and certain provisions of the existing financial covenants were modified by the Fourth Amendment. As of April 30, 2025, we believe we are in compliance with all of our covenants in the Further Amended Credit Agreement.

The Fourth Amendment also provided a waiver of the events of default that had occurred under the Amended Credit Agreement as a result of our failure to comply with the maximum consolidated leverage ratio and the minimum consolidated fixed charge coverage ratio in effect thereunder for our fiscal measurement period ended January 31, 2025 as described above.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Further Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other

amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Further Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests we hold in ANI Scandinavia ApS, AstroNova GmbH, AstroNova SAS and the Purchaser), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island, and are guaranteed by, and secured by substantially all of the personal property assets of, Astro Machine.

Equipment Financing

In January 2024, we entered into a secured equipment loan facility agreement with Banc of America Leasing & Capital, LLC and borrowed a principal amount of $0.8 million thereunder for the purpose of financing our purchase of production equipment. This loan matures on January 23, 2029 and bears interest at a fixed rate of 7.06%. Under this loan agreement, equal monthly payments including principal and interest of $16,296 commenced on February 23, 2024, and will continue through the maturity of the equipment loan facility on January 23, 2029.

Assumed Financing Obligations of MTEX

In connection with our acquisition of MTEX, on the May 6, 2024 closing date of this acquisition we assumed certain existing financing obligations of MTEX that remain outstanding as of April 30, 2025. The long-term debt obligations of MTEX that remain outstanding include a term loan (the “MTEX Term Loan”) pursuant to an agreement dated December 22, 2023 (the “MTEX Term Loan Agreement”) between MTEX and Caixa Central de Crédito Agricola Mutuo. The MTEX Term Loan, which provides for a term loan in the principal amount of EUR 1.4 million ($1.6 million) and bears interest at a fixed rate of 6.022% per annum, requires monthly principal and interest payments totaling EUR 17,402 ($18,795) commencing in October 2024 and continuing through maturity on December 21, 2033.

MTEX has also received government assistance in the form of interest-free loans from government agencies located in Portugal (the “MTEX Government Grant Term Loans”). The MTEX Government Grant Term Loans are to be repaid to the applicable government agencies and are classified as long-term debt. The current balance of the MTEX Government Grants Term Loans as of April 30, 2025 is EUR 0.7 million ($0.8 million). The MTEX Government Grant Term Loans provide interest-free financing so long as monthly principal payments are made. In the event that MTEX and the applicable government agency renegotiate the payment dates, interest will be calculated according to a rate determined by the government agency as of the date of renegotiation and added to the outstanding principal payments. The MTEX Government Grant Term Loans mature at different dates through January 2027.

Additionally, we assumed short-term financing obligations of MTEX including letters of credit, maturing term loans, and financing arrangements for working capital classified as debt of which $0.3 million remains outstanding as of April 30, 2025.

Summary of Outstanding Debt

Revolving Credit Facility

At April 30, 2025, we had an outstanding balance of $18.3 million under our revolving credit facility under the Further Amended Credit Agreement. The balance outstanding under the revolving credit facility bore interest at a weighted average annual rate of 7.11% and 7.53%, and we incurred $375,000 and $132,000 for interest on this obligation, during the three months ended April 30, 2025 and April 27, 2024, respectively. Additionally, during the three months ended April 30, 2025 and April 27, 2024, we incurred $8,000 and $11,000, respectively, of commitment fees on the undrawn portion of our revolving credit facility. Both the interest expense and commitment fees are included as interest expense in the accompanying condensed consolidated statements of income (loss) for all periods presented. At April 30, 2025, $6.7 million remained available for borrowing under our revolving credit facility under the Further Amended Credit Agreement. Additionally, MTEX has a EUR 0.5 million ($0.5 million) available line of credit with Caixa Central de Crédito Agricola Mutuo. This credit line was established in December 2023 and is renewable every six months. There was EUR 0.1 million ($0.1 million) outstanding on this line of credit as of April 30, 2025.

 

 

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

 

(In thousands)

 

April 30,
2025

 

 

January 31,
2025

 

USD Term Loan (7.28% as of April 30, 2025 and 6.90% as of January 31, 2025); maturity date of August 4, 2027

 

$

9,125

 

 

$

9,450

 

Euro Term Loan (5.20% as of April 30, 2025 and 5.38% as of January 31, 2025); maturity date of August 4, 2027

 

 

13,916

 

 

 

12,719

 

MTEX Euro Term Loan (6.022% Fixed Rate); maturity date of December 21, 2033

 

 

1,619

 

 

 

1,514

 

MTEX Euro Government Grant Term Loan (0% as of April 30, 2025 and January 31, 2024); maturity dates through January 2027

 

 

818

 

 

 

876

 

Equipment Loan (7.06% Fixed Rate); maturity date of January 23, 2029

 

 

642

 

 

 

680

 

    Total Debt

 

$

26,120

 

 

$

25,239

 

    Less: Debt Issuance Costs, net of accumulated amortization

 

 

77

 

 

 

85

 

             Current Portion of Debt

 

 

6,041

 

 

 

6,110

 

Long-Term Debt

 

$

20,002

 

 

$

19,044

 

During the three months ended April 30, 2025 and April 27, 2024, we recognized interest expense on term debt of $379,000 and $233,000, respectively, which is recognized in the accompanying condensed consolidated statements of income for all periods presented.

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of April 30, 2025 is as follows:

 

 

(In thousands)

 

 

 

Fiscal 2026, remainder

 

$

4,476

 

Fiscal 2027

 

 

6,052

 

Fiscal 2028

 

 

14,214

 

Fiscal 2029

 

 

362

 

Fiscal 2030

 

 

1,016

 

 

$

26,120

 
v3.25.1
Financial Instruments and Risk Management
 3 Months Ended
Apr. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments and Risk Management

Note 10 – Financial Instruments and Risk Management

We use foreign currency-denominated debt to partially hedge our net investment in our operations in Europe against adverse movements in exchange rates. Commencing on August 3, 2024, a portion of the Euro-denominated debt has been designated and was effective as an economic hedge of part of the net investment in our Portuguese operation. On January 31, 2025, we assessed the effectiveness of the net investment hedge and determined that it was no longer highly effective. Accordingly, future changes in the carrying value of this nonderivative hedging instrument would have to be recorded in “other expenses” in the consolidated statements of income (loss). To address this situation, effective January 31, 2025, the Euro-denominated debt has been designated as an economic hedge of part of our net investment in our German operation to replace part of our net investment in our Portuguese operation. As a result, foreign currency transaction gains or losses due to spot rate fluctuations on the Euro-denominated debt are included in the foreign currency translation adjustments in the condensed consolidated statement of comprehensive income for the three months ended April 30, 2025, and within the accumulated other comprehensive items in the shareholder’s equity section of the condensed consolidated balance sheet as of April 30, 2025 as follows:
 

(In thousands)

 

Amount of Foreign Currency Translation Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative

 

Financial Instruments Designated as Net Investment Hedge

 

April 30,
2025

 

 

April 27, 2024

 

     Euro Denominated Debt

 

$

(472

)

 

$

—

 

 
v3.25.1
Royalty Obligation
 3 Months Ended
Apr. 30, 2025
Royalty Obligation Disclosure [Abstract]  
Royalty Obligation

Note 11 – Royalty Obligation

In fiscal 2018, we entered into an Asset Purchase and License Agreement with Honeywell International, Inc. (“Honeywell”) to acquire an exclusive, perpetual, world-wide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years, based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, the product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments. As of April 30, 2025, we had paid an aggregate of $13.3 million of the guaranteed minimum royalty obligation. At April 30, 2025, the current portion of the outstanding guaranteed minimum royalty obligation of $1.0 million is to be paid over the next twelve months and is reported as a current liability and the remainder of $0.7 million is reported as a long-term liability on our condensed consolidated balance sheet. For the three months ended April 30, 2025 and April 27, 2024, we incurred $0.6 million and $0.5 million, respectively, in excess royalty expense which is included in cost of revenue in our consolidated statements of income for all periods presented. A total of $0.6 million in excess royalties was paid through the first quarter of the current fiscal year, and there are $0.6 million in excess royalty payables due as a result of this agreement for the quarter ended April 30, 2025.

In fiscal 2023, we entered into an Asset Purchase and License Agreement with Honeywell International Inc. (the “New HW Agreement”) to acquire an exclusive, perpetual, world-wide license to manufacture Honeywell’s flight deck printers for the Boeing 787 aircraft. The New HW Agreement provides for royalty payments to Honeywell based on gross revenues from the sales of the printers, paper and repair services of the licensed products in perpetuity. The royalty rates vary based on the year in which they are paid or earned and as products are sold or as services are provided and range from single-digit to mid-double-digit percentages of gross revenue. The New HW Agreement includes a provision for guaranteed minimum royalty payments to be paid in the event that the royalties earned by Honeywell do not meet the minimum for the preceding calendar year as follows: $100,000 in 2024, $200,000 in 2025, $233,000 in each of 2026 and 2027, and $234,000 in 2028.

As of April 30, 2025, the total outstanding royalty obligation under the New HW Agreement was $0.5 million, including $0.2 million recorded as a current liability in the accompanying condensed consolidated balance sheet.
v3.25.1
Leases
 3 Months Ended
Apr. 30, 2025
Leases [Abstract]  
Leases

Note 12 – Leases

We enter into lease contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of one to ten years, some of which include options to extend the lease term for periods of up to five years when it is reasonably certain that we will exercise such options.

Balance sheet and other information related to our leases is as follows:

Operating Leases (In thousands)

 

Balance Sheet Classification

 

April 30,
2025

 

 

January 31,
2025

 

Lease Assets

 

Right of Use Assets

 

$

2,763

 

 

$

1,781

 

Lease Liabilities – Current

 

Other Accrued Expenses

 

$

528

 

 

$

320

 

Lease Liabilities – Long Term

 

Lease Liabilities

 

$

2,318

 

 

$

1,535

 

Lease cost information is as follows:

 

 

 

Three Months
Ended

 

Operating Leases (In thousands)

 

Statement of Income Classification

 

April 30,
2025

 

 

April 27,
2024

 

Operating Lease Costs

 

General and Administrative Expense

 

$

158

 

 

$

88

 

 

 

 

 

 

 

 

 

 

 

Maturities of operating lease liabilities are as follows:

(In thousands)

 

April 30,
2025

 

Fiscal 2026, remaining

 

$

517

 

Fiscal 2027

 

 

676

 

Fiscal 2028

 

 

614

 

Fiscal 2029

 

 

445

 

Fiscal 2030

 

 

352

 

Thereafter

 

 

832

 

Total Lease Payments

 

 

3,436

 

Less: Imputed Interest

 

 

(590

)

Total Lease Liabilities

 

$

2,846

 

As of April 30, 2025, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 6.0 years and 6.06%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Supplemental cash flow information related to leases is as follows:

 

Three Months
Ended

 

(In thousands)

 

April 30,
2025

 

 

April 27,
2024

 

Cash paid for operating lease liabilities

 

$

144

 

 

$

85

 
v3.25.1
Government Grants
 3 Months Ended
Apr. 30, 2025
Government Grants [Abstract]  
Government Grants

Note 13 – Government Grants

Our recently acquired subsidiary, MTEX, receives grants from its local government in Portugal to support its operations and various capital projects. We account for these government grants by analogy to International Accounting Standards 20, “Accounting for Government Grants and Disclosure of Government Assistance”, which follows a grant accounting model. Under this accounting framework, government assistance is recognized when it is probable we will receive assistance and comply with the conditions attached to the assistance. Operational related assistance is recorded on a systematic basis over the periods in which the related costs or expenditures have occurred and is presented as a reduction in the expense for which it is intended to defray. Capital related assistance is recorded as long-term deferred revenue and is recognized in cost of revenue as an offset against depreciation expense over the applicable asset's useful life.

The grant programs have various execution periods - some ending in May 2025 and others continuing through November 2026. The government agencies may verify compliance with the conditions established in the contracts during the investment phase and upon completion and are entitled to propose adjustments and require reimbursement if the contracts do not meet the specifications. Historically, no significant corrections or returns have occurred. As of April 30, 2025, there are no contingencies associated with the government grants.

The capital related government contracts between the Portuguese government and MTEX are defined on a grant-by-grant basis, with partial reimbursement of the assets acquired in connection with these grants. We have $1.4 million of short and long-term deferred revenue for capital related government grants which is included in the accompanying condensed consolidated balance sheet as of April 30, 2025, and we have recognized $0.1 million of grant revenue, included in cost of revenue as an offset to depreciation expense in the condensed consolidated statement of income for the three months ended April 30, 2025.

Under the operational related assistance grants, MTEX commits to research and development projects that the Portuguese government partially reimburses. We have recognized $0.2 million of grant revenue for our operational related assistance grants which is offset against the expenditures recognized for those grants and is included in selling and marketing expense in the accompanying condensed consolidated statement of income for the three months ended April 30, 2025.

v3.25.1
Accumulated Other Comprehensive Loss
 3 Months Ended
Apr. 30, 2025
Equity [Abstract]  
Accumulated Other Comprehensive Loss

Note 14 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:
 

(In thousands)

 

Foreign
Currency
Translation
Adjustments

 

Balance at January 31, 2025

 

$

(3,349

)

Other Comprehensive Income

 

 

975

 

Balance at April 30, 2025

 

$

(2,374

)

The amounts presented above are net of taxes except for translation adjustments associated with our German and Danish subsidiaries. The foreign cumulative translation adjustment includes translation adjustments and net investment hedges. See Note 10, “Financial Instruments and Risk Management” for additional disclosures about the net investment hedge.
v3.25.1
Share-Based Compensation
 3 Months Ended
Apr. 30, 2025
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation

Note 15 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (“RSAs”). At the June 6, 2023 annual meeting of shareholders, the 2018 Plan was amended to increase the number of shares of our common stock available for issuance by 600,000, bringing the total number of shares available for issuance under the 2018 Plan from 950,000 to 1,550,000. Under the 2018 Plan, we may also issue an additional number of shares equal to the number of shares subject to outstanding awards under our prior 2015 Equity Incentive Plan that are

forfeited, canceled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were 196,147 unvested RSUs; 60,615 unvested PSUs; and options to purchase an aggregate of 130,500 shares outstanding as of April 30, 2025.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 Plan or 2015 Plan, but outstanding awards will continue to be governed by those plans. As of April 30, 2025, options to purchase an aggregate of 118,449 shares were outstanding under the 2007 Plan and options to purchase an aggregate of 112,600 shares were outstanding under the 2015 Plan.

We also have a Non-Employee Director Annual Compensation Program (the “Program”) under which each non-employee director receives an automatic grant of RSAs on the date of the regular full meeting of the Board of Directors held each fiscal quarter. Under the Program, the number of whole shares to be granted each quarter is equal to 25% of the number calculated by dividing the director’s annual compensation amount by the fair market value of our stock on such day. On June 11, 2024, the director’s annual compensation amount was adjusted to be $72,800. All RSAs granted under this Program vest immediately.

Share-based compensation expense was recognized as follows:

 

 

Three Months Ended

 

(In thousands)

 

April 30,
2025

 

 

April 27,
2024

 

Stock Options

 

$

—

 

 

$

—

 

Restricted Stock Awards and Restricted Stock Units

 

 

281

 

 

 

319

 

Employee Stock Purchase Plan

 

 

25

 

 

 

6

 

Total

 

$

306

 

 

$

325

 

Stock Options

Aggregated information regarding stock option activity for the three months ended April 30, 2025, is summarized below:

 

 

Number of
Options

 

 

Weighted Average
Exercise Price

 

Outstanding at January 31, 2025

 

 

421,699

 

 

$

15.52

 

Granted

 

 

—

 

 

 

—

 

Exercised

 

 

—

 

 

 

—

 

Forfeited

 

 

—

 

 

 

—

 

Canceled

 

 

(60,150

)

 

 

13.95

 

Outstanding at April 30, 2025

 

 

361,549

 

 

$

15.78

 

 

Set forth below is a summary of options outstanding at April 30, 2025:

 

Outstanding

 

 

Exercisable

 

Range of
Exercise prices

 

Number
of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual Life

 

 

Number
of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual Life

 

$10.01-15.00

 

 

155,074

 

 

$

13.61

 

 

 

1.2

 

 

 

155,074

 

 

$

13.61

 

 

 

1.2

 

$15.01-20.00

 

 

206,475

 

 

$

17.42

 

 

 

2.4

 

 

 

206,475

 

 

$

17.42

 

 

 

2.4

 

 

 

361,549

 

 

$

15.78

 

 

 

1.9

 

 

 

361,549

 

 

$

15.78

 

 

 

1.9

 

 

There were no stock options granted in fiscal 2025, or during the first three months of fiscal 2026, and as of April 30, 2025, there was no unrecognized compensation expense related to stock options.

Restricted Stock Units (RSUs), Performance-Based Stock Units (PSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU, PSU and RSA activity for the three months ended April 30, 2025, is summarized below:

 

 

RSUs, PSUs & RSAs

 

 

Weighted Average
Grant Date Fair Value

 

Outstanding at January 31, 2025

 

 

253,777

 

 

$

14.07

 

Granted

 

 

133,773

 

 

 

8.23

 

Vested

 

 

(65,550

)

 

 

13.30

 

Forfeited

 

 

(65,238

)

 

 

14.12

 

Outstanding at April 30, 2025

 

 

256,762

 

 

$

11.21

 

As of April 30, 2025, there was approximately $1.9 million of unrecognized compensation expense related to RSUs, PSUs and RSAs, which is expected to be recognized over a weighted average period of 2.4 years.

Employee Stock Purchase Plan (ESPP)

Our ESPP allowed eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 40,000 shares were initially reserved for issuance under the ESPP. During the three months ended April 30, 2025, there were 6,463 shares purchased under the ESPP and there were 6,045 shares remaining available for purchase under the ESPP as of April 30, 2025. The Board of Directors terminated the ESPP effective April 22, 2025. Upon termination and in accordance with its terms, all payroll deductions made for the second quarter offer period which began on April 1, 2025, were refunded to the participating employees.
v3.25.1
Income Taxes
 3 Months Ended
Apr. 30, 2025
Income Tax Disclosure [Abstract]  
Income Taxes

Note 16– Income Taxes

Our effective tax rates are as follows:

 

First Quarter

 

Fiscal 2026

 

 

(24.9

)%

Fiscal 2025

 

 

(58.1

)%

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted pre-tax income and facts known at that time. The estimated annual effective tax rate is applied to the year-to-date pre-tax income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended April 30, 2025, we recognized an income tax expense of $75,000. The effective tax rate in this period was directly impacted by a $109,000 tax expense related to the return to provision associated with our fiscal 2023 amended state tax returns. Additional impacts on the effective tax rate included a $62,000 tax expense arising from shortfall tax expense related to our stock and a $26,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position. During the three months ended April 27, 2024, we recognized an income tax benefit of $434,000. The effective tax rate in this period was directly impacted by a $572,000 tax benefit related to a previously unrecorded reduction in our future income taxes payable balance that should have been discretely recognized in the fourth quarter of fiscal year 2024 when we completed our domestic return to accrual process. Additional impacts on the effective tax rate included a $75,000 tax benefit arising from windfall tax benefits related to our stock.
v3.25.1
Segment Information
 3 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Segment Information

Note 17 – Segment Information

Our operations consist of the design, development, manufacture and sale of specialty printers and data acquisition and analysis systems, including both hardware and software and related consumable supplies. We organize and manage our business as a portfolio of products and services designed around a common theme of data acquisition and information output.

We have two reporting segments consistent with our revenue product groups: Product ID and Aerospace . Effective February 1, 2025, we changed the name of our Test & Measurement segment to “Aerospace” to better reflect the end markets we serve in that segment. The segment name change did not result in any change to the composition of our reportable segments and, therefore, did not

result in any changes to our historical segment results or the way our chief operating decision maker (“CODM”) allocates resources or makes decisions.

Our Product ID segment produces an array of high-technology digital color and monochrome label printers, commercial presses, direct to package/overprint printers, mail and sheet/flatpack printers and flexible packaging printers as well as supplies for a variety of industries worldwide. Our Aerospace segment produces our line of aerospace flight deck and cabin printers, as well as specialty airborne certified networking equipment and related supplies and services. The Aerospace segment also includes data acquisition systems used worldwide for a variety of recording, monitoring and troubleshooting applications for many industries including aerospace, defense, rail, energy, industrial and general manufacturing.

Our CODM has been identified as the President and Chief Executive Officer. The CODM regularly receives and uses discrete financial information about each reporting segment which is used for performance assessments and resource allocation decisions. The CODM evaluates the performance of and allocates resources to the reporting segments based on segment profit or loss, which represents the segments’ income (loss) before income taxes and excludes corporate expenses. The accounting policies of the reporting segments are the same as those described in the summary of significant accounting policies included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2025.

The CODM does not evaluate reportable segment asset or liability information, and as such, assets are reported on a consolidated basis only.

Business is conducted in the United States and through foreign branch offices and subsidiaries in Canada, Europe, China, Southeast Asia and Mexico. Manufacturing activities are primarily conducted in the United States. Revenue and service activities outside the United States are conducted through wholly owned entities and, to a lesser extent, through authorized distributors and agents. Transfer prices are intended to produce gross profit margins as would be associated with an arms-length transaction.

 

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

 

 

Three Months
Ended

 

($ in thousands)

 

April 30,
2025

 

 

April 27,
2024

 

Revenue:

 

 

 

 

 

 

  Product ID

 

$

26,289

 

 

$

23,185

 

  Aerospace

 

 

11,419

 

 

 

9,776

 

     Total Revenue

 

$

37,708

 

 

$

32,961

 

 

 

 

 

 

 

 

Cost of Revenue:

 

 

 

 

 

 

  Product ID

 

$

17,561

 

 

$

14,859

 

  Aerospace

 

 

7,495

 

 

 

6,130

 

     Total Cost of Revenue

 

$

25,056

 

 

$

20,989

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

  Product ID (1)

 

$

5,937

 

 

$

5,335

 

  Aerospace(1)

 

 

1,160

 

 

 

1,924

 

     Total Operating Expenses

 

$

7,097

 

 

$

7,259

 

 

 

 

 

 

 

 

 Segment Operating Income:

 

 

 

 

 

 

  Product ID

 

$

2,791

 

 

$

2,991

 

  Aerospace

 

 

2,764

 

 

 

1,722

 

     Total Segment Operating Income

 

$

5,555

 

 

$

4,713

 

 

 

 

 

 

 

 

   Corporate Expense (2)

 

 

(4,984

)

 

 

(3,367

)

Operating Income

 

$

571

 

 

$

1,346

 

Interest Expense

 

 

(897

)

 

 

(482

)

Other Income (Expense) (3)

 

 

25

 

 

 

(117

)

Income (Loss) Before Income Taxes

 

$

(301

)

 

$

747

 

Income Tax Provision (Benefit)

 

 

75

 

 

 

(434

)

Net Income (Loss)

 

$

(376

)

 

$

1,181

 

 

 

 

 

 

 

 

(1) Product ID and Aerospace segment operating expenses include Selling and Marketing and Research and Development.

(2) The amounts included in Corporate Expenses consist of executive and finance compensation, acquisition and integration costs, restructuring costs, professional fees as well as certain other non-recurring costs not allocated to the reporting segments.

(3) Includes gain/(loss) on foreign exchange and other miscellaneous income/(expense) not allocated to the reporting segments.

Revenue by product type for each reporting segment:

 

 

 

 

 

 

 

April 30,

 

 

April 27,

 

($ in thousands)

2025

 

 

2024

 

  Product ID :

 

 

 

 

 

     Hardware

$

4,776

 

 

$

3,802

 

     Supplies

 

19,877

 

 

 

17,581

 

     Other

 

1,636

 

 

 

1,802

 

        Total Product ID Revenue

 

26,289

 

 

 

23,185

 

  Aerospace:

 

 

 

 

 

     Hardware

 

6,519

 

 

 

5,073

 

     Supplies

 

1,204

 

 

 

1,053

 

     Other

 

3,696

 

 

 

3,650

 

       Total Aerospace Revenue

 

11,419

 

 

 

9,776

 

       Total Revenue

$

37,708

 

 

$

32,961

 

Other information by segment is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

Capital Expenditures

 

 

 

April 30,

 

 

April 27,

 

 

April 30,

 

 

April 27,

 

(In thousands)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Product ID

 

$

973

 

 

$

591

 

 

$

60

 

 

$

492

 

Aerospace

 

 

317

 

 

 

320

 

 

 

—

 

 

 

—

 

Total

 

$

1,290

 

 

$

911

 

 

$

60

 

 

$

492

 
v3.25.1
Fair Value
 3 Months Ended
Apr. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value

Note 18 – Fair Value

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

 

 

April 30, 2025

 

 

Fair Value Measurement

 

 

 

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Carrying Value

 

Long-Term debt and related current maturities

 

$

—

 

 

$

—

 

 

$

24,661

 

 

$

24,661

 

 

$

26,120

 

 

 

January 31, 2025

 

 

Fair Value Measurement

 

 

 

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Carrying Value

 

Long-Term debt and related current maturities

 

$

—

 

 

$

—

 

 

$

25,202

 

 

$

25,202

 

 

$

25,239

 

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

v3.25.1
Restructuring
 3 Months Ended
Apr. 30, 2025
Restructuring and Related Activities [Abstract]  
Restructuring

Note 19 - Restructuring

On March 20, 2025, we announced our restructuring actions for fiscal 2026, which include the reduction of approximately 10% of the Company’s global workforce, primarily in the Product ID segment, and the realignment of our underperforming MTEX operation in Portugal. As part of this initiative, we have cut approximately 70% of the MTEX product portfolio, phasing out low-volume, low-profit and developmental models in the nascent fabric printing market to focus more resources on much higher-margin products that capitalize on our supplies business. In addition, all MTEX sales, marketing and customer support functions have been integrated into our global teams to improve accountability and performance. We anticipate our restructuring actions to generate $3.0 million in annualized savings and expect to substantially complete the plan actions in the first half of fiscal 2026.

 

As a result of the adoption and implementation of our Product ID segment restructuring plan, in the first quarter of fiscal 2026 we recognized a pre-tax restructuring charge of $0.6 million, comprised primarily of cash charges related to severance-related costs. We paid $0.1 million of this restructuring charge as of April 30, 2025, and the remaining $0.5 million was included in other accrued expenses in the accompanying condensed consolidated balance sheet as of April 30, 2025, and is expected to be paid by the end of fiscal 2026.

The following table summarizes restructuring costs included in the accompanying condensed consolidated statement of income (loss) for the three months ended April 30, 2025:

 

 

 

 

 

(in thousands)

 

 

 

Cost of Revenue

 

$

340

 

Operating Expenses:

 

 

 

Selling & Marketing

 

 

98

 

Research & Development

 

 

—

 

General & Administrative

 

 

120

 

Total

 

$

558

 
v3.25.1
Summary of Significant Accounting Policies Update (Policies)
 3 Months Ended
Apr. 30, 2025
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Recent Accounting Pronouncements Not Yet Adopted

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the Financial Accounting Standards Board ( “FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” ASU 2024-03 enhances expense disclosures on both an annual and interim basis by requiring public entities to disclose additional information about specific expense categories in the notes to the consolidated financial statements. This ASU requires disclosure in tabular format of purchases of inventory, employee compensation, depreciation, intangible asset amortization and depletion, as applicable, for each income statement line item that contains those expenses. Specific expenses, gains and losses that are already disclosed under existing US GAAP are also required to be included in the disaggregated income statement expense line-item disclosures, and any remaining amounts will need to be described quantitatively. Additionally, ASU 2024-03 requires disclosure of the total amount of selling expenses and the entity’s definition of selling expenses. ASU 2024-03 is effective for the first annual disclosure period beginning after December 15, 2026 and for the interim periods subsequent to that, with early adoption permitted. The amendment should be applied prospectively; however, retrospective application is permitted. We are currently evaluating the new disclosure requirements of ASU 2024-04 and do not expect the adoption of this guidance to have a material impact on our consolidated financial statements or disclosures.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” to enhance the transparency and decision usefulness of income tax disclosures primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 modifies the requirement for income tax disclosures to include (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic

and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact and related disclosures required as a result of adopting this new guidance within our Annual Report on Form 10-K for the year ended January 31, 2026 and subsequent annual reports.

No other new accounting pronouncements, issued or effective during the first three months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

v3.25.1
Acquisition (Tables)
 3 Months Ended
Apr. 30, 2025
Business Acquisition [Line Items]  
Schedule of Fair Value of the Consideration Transferred as of the Acquisition Closing Date

A summary of the fair value of the consideration transferred as of the acquisition closing date is presented in the table below:

(In thousands)

 

Preliminary Estimate

 

 

Measurement Period Adjustment

 

 

Final

 

Cash Paid at Closing

 

$

18,732

 

 

$

(1

)

 

$

18,731

 

Holdback Amount

 

 

742

 

 

 

—

 

 

 

742

 

Fair Value of the Earnout

 

 

1,619

 

 

 

(1,619

)

 

 

—

 

Total Purchase Price

 

$

21,093

 

 

$

(1,620

)

 

$

19,473

 
MTEX New Solutions, S.A. [Member]  
Business Acquisition [Line Items]  
Summary of Purchase Price of Acquisition Allocated on Basis of Fair Value

The following table sets forth the final purchase price allocation of the MTEX acquisition for the estimated fair value of the net assets acquired and liabilities assumed as of May 6, 2024:

 

(In thousands)

 

Preliminary Estimate

 

 

Measurement Period Adjustment

 

 

Final Purchase Price Allocation

 

Cash

 

$

364

 

 

$

—

 

 

$

364

 

Accounts Receivable

 

 

3,989

 

 

 

(2,777

)

 

 

1,212

 

Inventory

 

 

3,807

 

 

 

(200

)

 

 

3,607

 

Prepaid Expenses and Other Current Assets

 

 

301

 

 

 

—

 

 

 

301

 

Property, Plant and Equipment

 

 

4,802

 

 

 

—

 

 

 

4,802

 

Other Long-Term Assets

 

 

5,154

 

 

 

1,054

 

 

 

6,208

 

Identifiable Intangible Assets

 

 

9,556

 

 

 

(2,017

)

 

 

7,539

 

Goodwill

 

 

10,629

 

 

 

3,650

 

 

 

14,279

 

Accounts Payable and Other Current Liabilities

 

 

(4,225

)

 

 

(1,870

)

 

 

(6,095

)

Debt Assumed

 

 

(7,918

)

 

 

—

 

 

 

(7,918

)

Other Long-Term Liabilities

 

 

(5,366

)

 

 

540

 

 

 

(4,826

)

Total Purchase Price

 

$

21,093

 

 

$

(1,620

)

 

$

19,473

 
Summary of Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives

The following table reflects the preliminary fair value of the acquired identifiable intangible assets and related estimated useful lives:

(In thousands)

 

Fair
Value

 

 

Measurement Period Adjustment

 

 

Final Fair Value

 

 

Useful Life
(years)

 

Customer Relations

 

$

8,786

 

 

$

(6,183

)

 

$

2,603

 

 

 

10

 

Internally Developed Technology

 

 

488

 

 

 

4,231

 

 

 

4,719

 

 

 

6

 

Trademarks/Tradenames

 

 

282

 

 

 

(65

)

 

 

217

 

 

 

3

 

Total

 

$

9,556

 

 

$

(2,017

)

 

$

7,539

 

 

 

 
Summary of Revenue and Earnings Before Taxes

The amounts of revenue and earnings before taxes attributable to MTEX and included in our consolidated statements of income for the three months ended April 30, 2025 were as follows:

 

 

 

 

 

(In thousands)

 

 

 

 

Revenue

 

$

1,402

 

(1)

Gross Profit

 

 

119

 

 

Operating Expenses:

 

 

 

 

   Selling Expenses

 

 

630

 

 

   Research and Development Expenses

 

 

171

 

 

   General and Administrative Expenses

 

 

236

 

 

      Total Operating Expenses

 

$

1,037

 

 

Operating Loss

 

 

(918

)

 

Other Expenses

 

 

(138

)

 

Earnings (Loss) before Taxes

 

$

(1,056

)

 

(1) Include $727,000 of MTEX revenue related to sales that were sold to third parties via intercompany sales.

*MTEX was acquired on May 6, 2024, and therefore no results are included in AstroNova consolidated income (loss) for the period ended April 27, 2024.
v3.25.1
Revenue Recognition (Tables)
 3 Months Ended
Apr. 30, 2025
Revenue from Contract with Customer [Abstract]  
Summary of Revenues Disaggregated by Primary Geographic Markets and Major Product Type

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:

 

 

Three Months Ended

 

 

(In thousands)

 

April 30, 2025

 

 

April 27, 2024*

 

 

United States

 

$

22,671

 

 

$

19,564

 

 

Europe

 

 

9,886

 

 

 

8,970

 

 

Canada

 

 

1,506

 

 

 

1,759

 

 

Asia

 

 

1,960

 

 

 

1,186

 

 

Central and South America

 

 

1,343

 

 

 

1,198

 

 

Other

 

 

342

 

 

 

284

 

 

Total Revenue

 

$

37,708

 

 

$

32,961

 

 

*Certain amounts have been reclassified to conform to the current year's presentation.

Major product types:

 

 

Three Months Ended

 

 

(In thousands)

 

April 30, 2025

 

 

April 27, 2024

 

 

Hardware

 

$

11,295

 

 

$

8,875

 

 

Supplies

 

 

21,080

 

 

 

18,633

 

 

Service and Other

 

 

5,333

 

 

 

5,453

 

 

Total Revenue

 

$

37,708

 

 

$

32,961

 

 
v3.25.1
Net Income (Loss) Per Common Share (Tables)
 3 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Net Income (Loss) Per Share A reconciliation of the shares used in calculating basic and diluted net income (loss) per share is as follows:

 

 

Three Months Ended

 

 

 

April 30, 2025

 

 

April 27, 2024

 

 

Weighted Average Common Shares Outstanding – Basic

 

 

7,559,704

 

 

 

7,459,394

 

 

Effect of Dilutive Options, Restricted Stock Awards and
   Restricted Stock Units

 

 

—

 

(1)

 

168,631

 

 

Weighted Average Common Shares Outstanding – Diluted

 

 

7,559,704

 

 

 

7,628,025

 

 

(1)For the three months ended April 30, 2025, we had weighted average common stock equivalent shares outstanding of 67,066 that could potentially dilute earnings per share in future periods. These shares were excluded from the computation of diluted earnings per share because their effect would have been anti-dilutive given the net loss during the period.
v3.25.1
Intangible Assets (Tables)
 3 Months Ended
Apr. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives

Intangible assets are as follows:

 

 

April 30, 2025

 

 

January 31, 2025

 

(In thousands)

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization

 

 

Currency
Translation
Adjustment

 

 

Net
Carrying
Amount

 

 

Gross
Carrying
Amount

 

 

Accumulated
Amortization

 

 

Currency
Translation
Adjustment

 

 

Net
Carrying
Amount

 

RITEC:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
       Relationships

 

$

2,830

 

 

$

(1,772

)

 

$

—

 

 

$

1,058

 

 

$

2,830

 

 

$

(1,755

)

 

$

—

 

 

$

1,075

 

TrojanLabel:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Distributor Relations

 

937

 

 

 

(798

)

 

 

33

 

 

 

172

 

 

937

 

 

 

(774

)

 

 

16

 

 

 

179

 

Honeywell:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
       Relationships

 

 

27,773

 

 

 

(13,878

)

 

 

—

 

 

 

13,895

 

 

 

27,773

 

 

 

(13,661

)

 

 

—

 

 

 

14,112

 

Astro Machine:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
      Relationships

 

 

3,060

 

 

 

(1,683

)

 

 

—

 

 

 

1,377

 

 

 

3,060

 

 

 

(1,530

)

 

 

—

 

 

 

1,530

 

   Trademarks

 

420

 

 

 

(231

)

 

 

—

 

 

 

189

 

 

420

 

 

 

(210

)

 

 

—

 

 

 

210

 

MTEX:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Customer Contract
      Relationships

 

 

2,603

 

 

 

(259

)

 

 

109

 

 

 

2,453

 

 

 

2,603

 

 

 

(194

)

 

 

(104

)

 

 

2,305

 

   Internally Developed Technology

 

 

4,719

 

 

 

(782

)

 

 

182

 

 

 

4,119

 

 

 

4,719

 

 

 

(586

)

 

 

(181

)

 

 

3,952

 

   Trademarks

 

 

217

 

 

 

(72

)

 

 

6

 

 

 

151

 

 

 

217

 

 

 

(54

)

 

 

(7

)

 

 

156

 

Intangible Assets, net

 

$

42,559

 

 

$

(19,475

)

 

$

330

 

 

$

23,414

 

 

$

42,559

 

 

$

(18,764

)

 

$

(276

)

 

$

23,519

 
Summary of Estimated Amortization Expense

Estimated amortization expense for the next five fiscal years is as follows:

 

(In thousands)

 

Remaining
2026

 

 

2027

 

 

2028

 

 

2029

 

 

2030

 

Estimated amortization expense

 

$

2,131

 

 

$

2,841

 

 

$

2,342

 

 

$

1,976

 

 

$

1,976

 
v3.25.1
Inventories (Tables)
 3 Months Ended
Apr. 30, 2025
Inventory Disclosure [Abstract]  
Components of Inventories The components of inventories are as follows:

 

(In thousands)

 

April 30, 2025

 

 

January 31, 2025

 

Materials and Supplies

 

$

36,153

 

 

$

35,181

 

Work-In-Process

 

 

2,843

 

 

 

2,559

 

Finished Goods

 

 

22,306

 

 

 

19,879

 

 

 

61,302

 

 

 

57,619

 

Inventory Reserve

 

 

(9,845

)

 

 

(9,725

)

 

$

51,457

 

 

$

47,894

 
v3.25.1
Property, Plant and Equipment (Tables)
 3 Months Ended
Apr. 30, 2025
Property, Plant and Equipment [Abstract]  
Summary of Property, Plant and Equipment

Property, plant and equipment consist of the following:

 

(In thousands)

 

April 30, 2025

 

 

January 31, 2025

 

Land and Land Improvements

 

$

2,304

 

 

$

2,304

 

Buildings and Leasehold Improvements

 

 

15,184

 

 

 

15,116

 

Machinery and Equipment

 

 

30,997

 

 

 

30,403

 

Computer Equipment and Software

 

 

14,565

 

 

 

14,538

 

Gross Property, Plant and Equipment

 

 

63,050

 

 

 

62,361

 

Accumulated Depreciation

 

 

(45,530

)

 

 

(44,722

)

Net Property Plant and Equipment

 

$

17,520

 

 

$

17,639

 

Depreciation expense on property, plant and equipment was $0.6 million and $0.4 million for the three months ended April 30, 2025 and April 27, 2024, respectively.

v3.25.1
Credit Agreement and Long-Term Debt (Tables)
 3 Months Ended
Apr. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

 

(In thousands)

 

April 30,
2025

 

 

January 31,
2025

 

USD Term Loan (7.28% as of April 30, 2025 and 6.90% as of January 31, 2025); maturity date of August 4, 2027

 

$

9,125

 

 

$

9,450

 

Euro Term Loan (5.20% as of April 30, 2025 and 5.38% as of January 31, 2025); maturity date of August 4, 2027

 

 

13,916

 

 

 

12,719

 

MTEX Euro Term Loan (6.022% Fixed Rate); maturity date of December 21, 2033

 

 

1,619

 

 

 

1,514

 

MTEX Euro Government Grant Term Loan (0% as of April 30, 2025 and January 31, 2024); maturity dates through January 2027

 

 

818

 

 

 

876

 

Equipment Loan (7.06% Fixed Rate); maturity date of January 23, 2029

 

 

642

 

 

 

680

 

    Total Debt

 

$

26,120

 

 

$

25,239

 

    Less: Debt Issuance Costs, net of accumulated amortization

 

 

77

 

 

 

85

 

             Current Portion of Debt

 

 

6,041

 

 

 

6,110

 

Long-Term Debt

 

$

20,002

 

 

$

19,044

 
Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of April 30, 2025 is as follows:

 

 

(In thousands)

 

 

 

Fiscal 2026, remainder

 

$

4,476

 

Fiscal 2027

 

 

6,052

 

Fiscal 2028

 

 

14,214

 

Fiscal 2029

 

 

362

 

Fiscal 2030

 

 

1,016

 

 

$

26,120

 
v3.25.1
Financial Instruments and Risk Management (Tables)
 3 Months Ended
Apr. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Net Investment Hedges

(In thousands)

 

Amount of Foreign Currency Translation Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative

 

Financial Instruments Designated as Net Investment Hedge

 

April 30,
2025

 

 

April 27, 2024

 

     Euro Denominated Debt

 

$

(472

)

 

$

—

 

 
v3.25.1
Leases (Tables)
 3 Months Ended
Apr. 30, 2025
Leases [Abstract]  
Schedule Of Balance Sheet And Other Information Related To Operating Leases

Balance sheet and other information related to our leases is as follows:

Operating Leases (In thousands)

 

Balance Sheet Classification

 

April 30,
2025

 

 

January 31,
2025

 

Lease Assets

 

Right of Use Assets

 

$

2,763

 

 

$

1,781

 

Lease Liabilities – Current

 

Other Accrued Expenses

 

$

528

 

 

$

320

 

Lease Liabilities – Long Term

 

Lease Liabilities

 

$

2,318

 

 

$

1,535

 
Schedule Lease Cost Information

Lease cost information is as follows:

 

 

 

Three Months
Ended

 

Operating Leases (In thousands)

 

Statement of Income Classification

 

April 30,
2025

 

 

April 27,
2024

 

Operating Lease Costs

 

General and Administrative Expense

 

$

158

 

 

$

88

 

 

 

 

 

 

 

 

 

 

 
Schedule of Maturities Of Lease Liabilities

Maturities of operating lease liabilities are as follows:

(In thousands)

 

April 30,
2025

 

Fiscal 2026, remaining

 

$

517

 

Fiscal 2027

 

 

676

 

Fiscal 2028

 

 

614

 

Fiscal 2029

 

 

445

 

Fiscal 2030

 

 

352

 

Thereafter

 

 

832

 

Total Lease Payments

 

 

3,436

 

Less: Imputed Interest

 

 

(590

)

Total Lease Liabilities

 

$

2,846

 
Supplemental Cash Flow Information Related To Leases

Supplemental cash flow information related to leases is as follows:

 

Three Months
Ended

 

(In thousands)

 

April 30,
2025

 

 

April 27,
2024

 

Cash paid for operating lease liabilities

 

$

144

 

 

$

85

 
v3.25.1
Accumulated Other Comprehensive Loss (Tables)
 3 Months Ended
Apr. 30, 2025
Equity [Abstract]  
Changes in Balance of Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:
 

(In thousands)

 

Foreign
Currency
Translation
Adjustments

 

Balance at January 31, 2025

 

$

(3,349

)

Other Comprehensive Income

 

 

975

 

Balance at April 30, 2025

 

$

(2,374

)
v3.25.1
Share-Based Compensation (Tables)
 3 Months Ended
Apr. 30, 2025
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Expense

Share-based compensation expense was recognized as follows:

 

 

Three Months Ended

 

(In thousands)

 

April 30,
2025

 

 

April 27,
2024

 

Stock Options

 

$

—

 

 

$

—

 

Restricted Stock Awards and Restricted Stock Units

 

 

281

 

 

 

319

 

Employee Stock Purchase Plan

 

 

25

 

 

 

6

 

Total

 

$

306

 

 

$

325

 
Aggregated Information Regarding Stock Option Activity

Aggregated information regarding stock option activity for the three months ended April 30, 2025, is summarized below:

 

 

Number of
Options

 

 

Weighted Average
Exercise Price

 

Outstanding at January 31, 2025

 

 

421,699

 

 

$

15.52

 

Granted

 

 

—

 

 

 

—

 

Exercised

 

 

—

 

 

 

—

 

Forfeited

 

 

—

 

 

 

—

 

Canceled

 

 

(60,150

)

 

 

13.95

 

Outstanding at April 30, 2025

 

 

361,549

 

 

$

15.78

 
Summary of Options Outstanding

Set forth below is a summary of options outstanding at April 30, 2025:

 

Outstanding

 

 

Exercisable

 

Range of
Exercise prices

 

Number
of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual Life

 

 

Number
of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual Life

 

$10.01-15.00

 

 

155,074

 

 

$

13.61

 

 

 

1.2

 

 

 

155,074

 

 

$

13.61

 

 

 

1.2

 

$15.01-20.00

 

 

206,475

 

 

$

17.42

 

 

 

2.4

 

 

 

206,475

 

 

$

17.42

 

 

 

2.4

 

 

 

361,549

 

 

$

15.78

 

 

 

1.9

 

 

 

361,549

 

 

$

15.78

 

 

 

1.9

 

 
Aggregated Information Regarding RSU, PSU and RSA Activity

Aggregated information regarding RSU, PSU and RSA activity for the three months ended April 30, 2025, is summarized below:

 

 

RSUs, PSUs & RSAs

 

 

Weighted Average
Grant Date Fair Value

 

Outstanding at January 31, 2025

 

 

253,777

 

 

$

14.07

 

Granted

 

 

133,773

 

 

 

8.23

 

Vested

 

 

(65,550

)

 

 

13.30

 

Forfeited

 

 

(65,238

)

 

 

14.12

 

Outstanding at April 30, 2025

 

 

256,762

 

 

$

11.21

 
v3.25.1
Income Taxes (Tables)
 3 Months Ended
Apr. 30, 2025
Income Tax Disclosure [Abstract]  
Projected Effective Tax Rates

Our effective tax rates are as follows:

 

First Quarter

 

Fiscal 2026

 

 

(24.9

)%

Fiscal 2025

 

 

(58.1

)%
v3.25.1
Segment Information (Tables)
 3 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Net Sales and Segment Operating Profit (Loss) for Each Reporting Segment

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

 

 

Three Months
Ended

 

($ in thousands)

 

April 30,
2025

 

 

April 27,
2024

 

Revenue:

 

 

 

 

 

 

  Product ID

 

$

26,289

 

 

$

23,185

 

  Aerospace

 

 

11,419

 

 

 

9,776

 

     Total Revenue

 

$

37,708

 

 

$

32,961

 

 

 

 

 

 

 

 

Cost of Revenue:

 

 

 

 

 

 

  Product ID

 

$

17,561

 

 

$

14,859

 

  Aerospace

 

 

7,495

 

 

 

6,130

 

     Total Cost of Revenue

 

$

25,056

 

 

$

20,989

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

  Product ID (1)

 

$

5,937

 

 

$

5,335

 

  Aerospace(1)

 

 

1,160

 

 

 

1,924

 

     Total Operating Expenses

 

$

7,097

 

 

$

7,259

 

 

 

 

 

 

 

 

 Segment Operating Income:

 

 

 

 

 

 

  Product ID

 

$

2,791

 

 

$

2,991

 

  Aerospace

 

 

2,764

 

 

 

1,722

 

     Total Segment Operating Income

 

$

5,555

 

 

$

4,713

 

 

 

 

 

 

 

 

   Corporate Expense (2)

 

 

(4,984

)

 

 

(3,367

)

Operating Income

 

$

571

 

 

$

1,346

 

Interest Expense

 

 

(897

)

 

 

(482

)

Other Income (Expense) (3)

 

 

25

 

 

 

(117

)

Income (Loss) Before Income Taxes

 

$

(301

)

 

$

747

 

Income Tax Provision (Benefit)

 

 

75

 

 

 

(434

)

Net Income (Loss)

 

$

(376

)

 

$

1,181

 

 

 

 

 

 

 

 

(1) Product ID and Aerospace segment operating expenses include Selling and Marketing and Research and Development.

(2) The amounts included in Corporate Expenses consist of executive and finance compensation, acquisition and integration costs, restructuring costs, professional fees as well as certain other non-recurring costs not allocated to the reporting segments.

(3) Includes gain/(loss) on foreign exchange and other miscellaneous income/(expense) not allocated to the reporting segments.
Summary of Revenue by Product Type

Revenue by product type for each reporting segment:

 

 

 

 

 

 

 

April 30,

 

 

April 27,

 

($ in thousands)

2025

 

 

2024

 

  Product ID :

 

 

 

 

 

     Hardware

$

4,776

 

 

$

3,802

 

     Supplies

 

19,877

 

 

 

17,581

 

     Other

 

1,636

 

 

 

1,802

 

        Total Product ID Revenue

 

26,289

 

 

 

23,185

 

  Aerospace:

 

 

 

 

 

     Hardware

 

6,519

 

 

 

5,073

 

     Supplies

 

1,204

 

 

 

1,053

 

     Other

 

3,696

 

 

 

3,650

 

       Total Aerospace Revenue

 

11,419

 

 

 

9,776

 

       Total Revenue

$

37,708

 

 

$

32,961

 
Summary of Other Information by Segment Other information by segment is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

 

Capital Expenditures

 

 

 

April 30,

 

 

April 27,

 

 

April 30,

 

 

April 27,

 

(In thousands)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Product ID

 

$

973

 

 

$

591

 

 

$

60

 

 

$

492

 

Aerospace

 

 

317

 

 

 

320

 

 

 

—

 

 

 

—

 

Total

 

$

1,290

 

 

$

911

 

 

$

60

 

 

$

492

 
v3.25.1
Fair Value (Tables)
 3 Months Ended
Apr. 30, 2025
Fair Value Disclosures [Abstract]  
Summary of Changes in Fair value of Level 3 Financial Liability

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

 

 

April 30, 2025

 

 

Fair Value Measurement

 

 

 

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Carrying Value

 

Long-Term debt and related current maturities

 

$

—

 

 

$

—

 

 

$

24,661

 

 

$

24,661

 

 

$

26,120

 

 

 

January 31, 2025

 

 

Fair Value Measurement

 

 

 

 

(In thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Carrying Value

 

Long-Term debt and related current maturities

 

$

—

 

 

$

—

 

 

$

25,202

 

 

$

25,202

 

 

$

25,239

 
v3.25.1
Restructuring (Tables)
 3 Months Ended
Apr. 30, 2025
Restructuring and Related Activities [Abstract]  
Summarizes Restructuring Costs

The following table summarizes restructuring costs included in the accompanying condensed consolidated statement of income (loss) for the three months ended April 30, 2025:

 

 

 

 

 

(in thousands)

 

 

 

Cost of Revenue

 

$

340

 

Operating Expenses:

 

 

 

Selling & Marketing

 

 

98

 

Research & Development

 

 

—

 

General & Administrative

 

 

120

 

Total

 

$

558

 
v3.25.1
Business and Basis of Presentation - Additional Information (Detail)
 3 Months Ended
Apr. 30, 2025
Segment
Business and Basis of Presentation [Line Items]  
Number of Operating Segments 2
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Operating Segments [Member] | Product ID [Member] | Hardware [Member]  
Business and Basis of Presentation [Line Items]  
Percentage of total revenue 20.00%
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Operating Segments [Member] | Product ID [Member] | Supplies, Parts and Service [Member]  
Business and Basis of Presentation [Line Items]  
Percentage of total revenue 80.00%
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Operating Segments [Member] | Aerospace [Member] | Hardware [Member]  
Business and Basis of Presentation [Line Items]  
Percentage of total revenue 55.00%
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Operating Segments [Member] | Aerospace [Member] | Supplies, Parts and Service [Member]  
Business and Basis of Presentation [Line Items]  
Percentage of total revenue 45.00%
v3.25.1
Acquisition - Additional Information (Detail)
 3 Months Ended 12 Months Ended
May 06, 2024
USD ($)
May 06, 2024
EUR (€)
May 04, 2024
Apr. 30, 2025
USD ($)
Jan. 31, 2025
USD ($)
Apr. 30, 2025
USD ($)
Jan. 31, 2025
USD ($)
Business Acquisition [Line Items]              
Goodwill       $ 15,232,000 $ 14,515,000 $ 15,232,000 $ 14,515,000
MTEX New Solutions, S.A. [Member]              
Business Acquisition [Line Items]              
Date of acquisition agreement     May 04, 2024        
Payments to Acquire Businesses, Gross 100.00%            
Closing date of acquisition May 06, 2024 May 06, 2024          
Purchase price of acquisition $ 18,700,000 € 17,268,345          
Potential earn-out payments $ 0            
Goodwill       14,300,000   14,300,000  
MTEX New Solutions, S.A. [Member] | PI [Member]              
Business Acquisition [Line Items]              
Goodwill impairment charges         $ 13,400,000    
MTEX New Solutions, S.A. [Member] | General and Administrative Expense [Member]              
Business Acquisition [Line Items]              
Business Combination, Acquisition Related Costs       $ 300,000   $ 1,500,000 $ 1,200,000
MTEX New Solutions, S.A. [Member] | Measurement Input Royalty Rate [Member]              
Business Acquisition [Line Items]              
Fair Value Of Intangible Assets Measurement Input 0.0075            
MTEX New Solutions, S.A. [Member] | Measurement Input, Discount Rate [Member]              
Business Acquisition [Line Items]              
Fair Value Of Intangible Assets Measurement Input 0.155     0.155   0.155  
MTEX New Solutions, S.A. [Member] | Maximum [Member]              
Business Acquisition [Line Items]              
Additional amount retained to secure indemnification obligations $ 800,000 € 731,655          
v3.25.1
Acquisition - Schedule of Fair Value of the Consideration Transferred as of the Acquisition Closing Date (Details) - May 06, 2024 - MTEX New Solutions, S.A. [Member]
$ in Thousands
EUR (€)
USD ($)
Business Acquisition [Line Items]    
Cash Paid at Closing € 17,268,345 $ 18,700
Preliminary Estimate [Member]    
Business Acquisition [Line Items]    
Cash Paid at Closing   18,732
Holdback Amount   742
Fair Value of the Earnout   1,619
Total Purcahse Price   21,093
Measurement Period Adjustment [Member[    
Business Acquisition [Line Items]    
Cash Paid at Closing   (1)
Fair Value of the Earnout   (1,619)
Total Purcahse Price   (1,620)
Revised Estimate [Member]    
Business Acquisition [Line Items]    
Cash Paid at Closing   18,731
Holdback Amount   742
Total Purcahse Price   $ 19,473
v3.25.1
Acquisition - Summary of Purchase Price of Acquisition Allocated on Basis of Fair Value (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
May 06, 2024
Business Acquisition [Line Items]      
Goodwill $ 15,232 $ 14,515  
MTEX New Solutions, S.A. [Member]      
Business Acquisition [Line Items]      
Goodwill $ 14,300    
MTEX New Solutions, S.A. [Member] | Preliminary Estimate [Member]      
Business Acquisition [Line Items]      
Cash     $ 364
Accounts Receivable     3,989
Inventory     3,807
Prepaid Expenses and Other Current Assets     301
Property, Plant and Equipment     4,802
Other Long-Term Assets     5,154
Identifiable Intangible Assets     9,556
Goodwill     10,629
Accounts Payable and Other Current Liabilities     (4,225)
Debt Assumed     (7,918)
Other Long-Term Liabilities     (5,366)
Total Purchase Price     21,093
MTEX New Solutions, S.A. [Member] | Measurement Period Adjustment [Member[      
Business Acquisition [Line Items]      
Accounts Receivable     (2,777)
Inventory     (200)
Other Long-Term Assets     1,054
Identifiable Intangible Assets     (2,017)
Goodwill     3,650
Accounts Payable and Other Current Liabilities     (1,870)
Other Long-Term Liabilities     540
Total Purchase Price     (1,620)
MTEX New Solutions, S.A. [Member] | Final Purchase Price Allocation [Member]      
Business Acquisition [Line Items]      
Cash     364
Accounts Receivable     1,212
Inventory     3,607
Prepaid Expenses and Other Current Assets     301
Property, Plant and Equipment     4,802
Other Long-Term Assets     6,208
Identifiable Intangible Assets     7,539
Goodwill     14,279
Accounts Payable and Other Current Liabilities     (6,095)
Debt Assumed     (7,918)
Other Long-Term Liabilities     (4,826)
Total Purchase Price     $ 19,473
v3.25.1
Acquisition - Summary of Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - MTEX New Solutions, S.A. [Member]
$ in Thousands
May 06, 2024
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]  
Fair Value $ 9,556
Measurement Period Adjustment (2,017)
Final Fair Value 7,539
Customer Relationships [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Fair Value 8,786
Measurement Period Adjustment (6,183)
Final Fair Value $ 2,603
Useful Life (Years) 10 years
Internally Developed Software [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Fair Value $ 488
Measurement Period Adjustment 4,231
Final Fair Value $ 4,719
Useful Life (Years) 6 years
Trademarks and Trade Names [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Fair Value $ 282
Measurement Period Adjustment (65)
Final Fair Value $ 217
Useful Life (Years) 3 years
v3.25.1
Acquisition - Summary of Revenue and Earnings Before Taxes (Detail) - MTEX New Solutions, S.A. [Member]
$ in Thousands
 3 Months Ended
Apr. 30, 2025
USD ($)
Business Acquisition Pro Forma Information [Line Items]  
Revenue $ 1,402 [1]
Gross Profit 119
Operating Expenses:  
Selling Expenses 630
Research and Development Expenses 171
General and Administrative Expenses 236
Total Operating Expenses 1,037
Operating Loss (918)
Other Expenses (138)
Earnings (Loss) before Taxes $ (1,056)
[1] Include $727,000 of MTEX revenue related to sales that were sold to third parties via intercompany sales.
v3.25.1
Acquisition - Summary of Revenue and Earnings Before Taxes (Parenthetical) (Detail) - MTEX New Solutions, S.A. [Member]
 3 Months Ended
Apr. 30, 2025
USD ($)
Business Acquisition Pro Forma Information [Line Items]  
Sales $ 1,402,000 [1]
Intercompany Sales [Member]  
Business Acquisition Pro Forma Information [Line Items]  
Sales $ 727,000
[1] Include $727,000 of MTEX revenue related to sales that were sold to third parties via intercompany sales.
v3.25.1
Revenue Recognition - Summary of Revenues Disaggregated by Primary Geographic Markets (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
 [1]
Disaggregation of Revenue [Line Items]    
Total Revenue $ 37,708 $ 32,961
United States [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 22,671 19,564
Europe [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 9,886 8,970
Canada [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 1,506 1,759
Asia [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 1,960 1,186
Central and South America [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 1,343 1,198
Other [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue $ 342 $ 284
[1] Certain amounts have been reclassified to conform to the current year's presentation.
v3.25.1
Revenue Recognition - Summary of Revenues Disaggregated by Primary Product Type (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Disaggregation of Revenue [Line Items]    
Total Revenue $ 37,708 $ 32,961 [1]
Hardware [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 11,295 8,875
Supplies [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue 21,080 18,633
Service and Other [Member]    
Disaggregation of Revenue [Line Items]    
Total Revenue $ 5,333 $ 5,453
[1] Certain amounts have been reclassified to conform to the current year's presentation.
v3.25.1
Revenue Recognition - Additional Information (Detail) - USD ($)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Jan. 31, 2025
Contract liabilities and extended warranties $ 565,000   $ 543,000
Revenue recognized $ 146,000    
Capitalized contract costs amounts incurred amortization period 16 years    
Contract assets balance     $ 1,500,000
Amortization of incremental direct costs $ 23,000 $ 19,000  
Deferred incremental direct costs net of accumulated amortization balance 1,500,000    
Deferred incremental direct contract costs reported in other current assets 100,000    
Aerospace Customer [Member]      
Deferred incremental direct contract costs reported in other assets $ 1,400,000    
v3.25.1
Net Income (Loss) Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted Net Income (Loss) per Share (Detail) - shares
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Earnings Per Share [Abstract]    
Weighted Average Common Shares Outstanding – Basic 7,559,704 7,459,394
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units 0 [1] 168,631
Weighted Average Number of Common Shares Outstanding—Diluted 7,559,704 7,628,025
[1] For the three months ended April 30, 2025, we had weighted average common stock equivalent shares outstanding of 67,066 that could potentially dilute earnings per share in future periods. These shares were excluded from the computation of diluted earnings per share because their effect would have been anti-dilutive given the net loss during the period.
v3.25.1
Net Income (Loss) Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted Net Income (Loss) per Share (Parenthetical) (Detail)
 3 Months Ended
Apr. 30, 2025
shares
Earnings Per Share [Abstract]  
Weighted average common stock equivalent shares outstanding 67,066
v3.25.1
Net Income (Loss) Per Common Share - Additional Information (Detail) - shares
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Earnings Per Share [Abstract]    
Number of common equivalent shares 451,199 181,999
v3.25.1
Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 42,559 $ 42,559
Accumulated Amortization (19,475) (18,764)
Currency Translation Adjustment 330 (276)
Net Carrying Amount 23,414 23,519
Customer Contract Relationships [Member] | Honeywell Asset Purchase and License Agreement [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 27,773 27,773
Accumulated Amortization (13,878) (13,661)
Net Carrying Amount 13,895 14,112
Customer Contract Relationships [Member] | RITEC [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,830 2,830
Accumulated Amortization (1,772) (1,755)
Net Carrying Amount 1,058 1,075
Customer Contract Relationships [Member] | MTEX New Solutions, S.A. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,603 2,603
Accumulated Amortization (259) (194)
Currency Translation Adjustment 109 (104)
Net Carrying Amount 2,453 2,305
Customer Contract Relationships [Member] | Agreement With Astro Machine For Asset Acquisitions [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 3,060 3,060
Accumulated Amortization (1,683) (1,530)
Net Carrying Amount 1,377 1,530
Distributor Relations [Member] | TrojanLabel [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 937 937
Accumulated Amortization (798) (774)
Currency Translation Adjustment 33 16
Net Carrying Amount 172 179
Internally Developed Technology [Member] | MTEX New Solutions, S.A. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 4,719 4,719
Accumulated Amortization (782) (586)
Currency Translation Adjustment 182 (181)
Net Carrying Amount 4,119 3,952
Trademarks [Member] | MTEX New Solutions, S.A. [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 217 217
Accumulated Amortization (72) (54)
Currency Translation Adjustment 6 (7)
Net Carrying Amount 151 156
Trademarks [Member] | Agreement With Astro Machine For Asset Acquisitions [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 420 420
Accumulated Amortization (231) (210)
Net Carrying Amount $ 189 $ 210
v3.25.1
Intangible Assets - Additional Information (Detail) - USD ($)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Impairment of Intangible Assets (Excluding Goodwill) [Abstract]    
Impairments of intangible assets $ 0 $ 0
Amortization expense $ 700,000 $ 400,000
v3.25.1
Intangible Assets - Summary of Estimated Amortization Expense (Detail)
$ in Thousands
Apr. 30, 2025
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
Remaining 2026 $ 2,131
2027 2,841
2028 2,342
2029 1,976
2030 $ 1,976
v3.25.1
Inventories - Components of Inventories (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Inventory Disclosure [Abstract]    
Materials and Supplies $ 36,153 $ 35,181
Work-In-Progress 2,843 2,559
Finished Goods 22,306 19,879
Inventory, Gross 61,302 57,619
Inventory Reserve (9,845) (9,725)
Inventories $ 51,457 $ 47,894
v3.25.1
Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Property, Plant and Equipment [Abstract]    
Land and Land Improvements $ 2,304 $ 2,304
Buildings and Leasehold Improvements 15,184 15,116
Machinery and Equipment 30,997 30,403
Computer Equipment and Software 14,565 14,538
Gross Property, Plant and Equipment 63,050 62,361
Accumulated Depreciation (45,530) (44,722)
Net Property Plant and Equipment $ 17,520 $ 17,639
v3.25.1
Property, Plant and Equipment - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Property, Plant and Equipment [Abstract]    
Depreciation expense on property, plant and equipment $ 0.6 $ 0.4
v3.25.1
Credit Agreement and Long- Term Debt - Additional Information (Detail)
 1 Months Ended 3 Months Ended 30 Months Ended
Apr. 30, 2025
USD ($)
Mar. 20, 2025
USD ($)
Nov. 02, 2024
EUR (€)
May 06, 2024
USD ($)
May 06, 2024
EUR (€)
Jan. 31, 2024
USD ($)
Apr. 30, 2025
USD ($)
Apr. 27, 2025
Apr. 27, 2024
USD ($)
Apr. 30, 2027
EUR (€)
Apr. 30, 2025
EUR (€)
Mar. 20, 2025
EUR (€)
Feb. 01, 2025
USD ($)
Jan. 31, 2025
USD ($)
May 06, 2024
EUR (€)
Debt Instrument [Line Items]                              
Interest Expense, Debt             $ 379,000   $ 233,000            
Outstanding principal balance   $ 9,500,000                   € 12,250,000,000,000      
Principal balance of term loan outstanding in year one   325,000                          
Principal balance of term loan outstanding in year two   725,000                          
Principal balance of term loan outstanding in year three   950,000                          
Short term debt obligation $ 327,000           327,000             $ 581,000  
Term Loan [Member]                              
Debt Instrument [Line Items]                              
Debt instrument, maturity date       Aug. 04, 2027 Aug. 04, 2027                    
Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Revolving loan outstanding 18,300,000 25,000,000         18,300,000                
Outstanding principal balance   $ 21,700,000                          
Interest rate   0.50%                          
Debt instrument, maturity date   Aug. 04, 2027                          
Banc of America Leasing & Capital, LLC [Member] | Equipment Loan Agreement [Member]                              
Debt Instrument [Line Items]                              
Principal amount of debt           $ 800,000                  
Debt instrument, maturity date           Jan. 23, 2029                  
Interest rate           7.06%                  
Periodic payment of debt           $ 16,296                  
Date of first required payment           Feb. 23, 2024                  
Term A-2 Loan [Member]                              
Debt Instrument [Line Items]                              
Debt instrument, maturity date       Aug. 04, 2027 Aug. 04, 2027                    
MTEX Term Loan [Member]                              
Debt Instrument [Line Items]                              
Revolving loan outstanding 100,000           100,000       € 100,000        
Short term debt obligation 300,000           300,000                
MTEX Government Grants Term Loan [Member]                              
Debt Instrument [Line Items]                              
Current balance of government grants 800,000           800,000       700,000        
SOFR [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Interest rate   1.00%                          
Federal Funds Effective Swap Rate [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Interest rate   0.50%                          
Minimum [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Commitment fee rate   15.00%                          
Minimum [Member] | EURIBOR Rate [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Interest rate   1.60%                          
Minimum [Member] | SOFR [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Percentage added to variable rate   0.60%                          
Maximum [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Commitment fee rate   40.00%                          
Maximum [Member] | EURIBOR Rate [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Interest rate   2.85%                          
Maximum [Member] | SOFR [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Percentage added to variable rate   1.85%                          
Bank of America, N.A. [Member] | Additional Term Loan Availed [Member]                              
Debt Instrument [Line Items]                              
Principal amount of debt | €                             € 14,000,000
Bank of America, N.A. [Member] | Before Amendment To The Credit Agreement [Member]                              
Debt Instrument [Line Items]                              
Principal amount of debt       $ 12,300,000                      
Bank of America, N.A. [Member] | Revolving Line of Credit [Member]                              
Debt Instrument [Line Items]                              
Available line of credit 6,700,000           $ 6,700,000                
Long term debt weighted average interest rate over a period of time             7.11% 7.53%              
Bank of America, N.A. [Member] | Revolving Line of Credit [Member] | Third Amendment Credit Agreement [Member]                              
Debt Instrument [Line Items]                              
Maximum borrowing capacity                         $ 25,000,000 $ 30,000,000  
Proceeds from long term line of credit | €         € 3,000,000                    
Bank of America, N.A. [Member] | Revolving Line of Credit [Member] | Before Amendment To The Credit Agreement [Member]                              
Debt Instrument [Line Items]                              
Maximum borrowing capacity       25,000,000                      
Bank of America, N.A. [Member] | Revolving Line of Credit [Member] | Other Expense [Member]                              
Debt Instrument [Line Items]                              
Interest Expense, Debt             $ 375,000   132,000            
Line of Credit Facility, Commitment Fee Amount             8,000   $ 11,000            
Bank of America, N.A. [Member] | Term A-2 Loan [Member] | Scenario Forecast [Member]                              
Debt Instrument [Line Items]                              
Debt Instrument, principal Periodic payment | €                   € 583,333          
Bank of America, N.A. [Member] | Term A-2 Loan [Member] | Third Amendment Credit Agreement [Member]                              
Debt Instrument [Line Items]                              
Proceeds from long term line of credit | €     € 14,000,000                        
Caixa Central de Credito Agricola Mutuo [Member] | MTEX Term Loan [Member]                              
Debt Instrument [Line Items]                              
Principal amount of debt       1,600,000                     € 1,400,000
Debt instrument principal and interest payments       $ 18,795 € 17,402                    
Line of Credit Facility, Current Borrowing Capacity $ 500,000           $ 500,000       € 500,000        
Payment terms       requires monthly principal and interest payments totaling EUR 17,402 ($18,795) commencing in October 2024 and requires monthly principal and interest payments totaling EUR 17,402 ($18,795) commencing in October 2024 and                    
Credit line established month and year 2023-12                            
Renewable Period 6 months                            
Debt instrument, maturity date       Dec. 21, 2033 Dec. 21, 2033                    
Interest rate       6.022%                     6.022%
v3.25.1
Credit Agreement and Long- Term Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Debt Instrument [Line Items]    
Total Debt $ 26,120 $ 25,239
Less: Debt Issuance Costs, net of accumulated amortization 77 85
Current Portion of Debt 6,041 6,110
Long-Term Debt 20,002 19,044
Term Loan Due August 4, 2027 [Member]    
Debt Instrument [Line Items]    
Total Debt 9,125 9,450
Term Loan Due August 4, 2027 [Member] | Euro [Member]    
Debt Instrument [Line Items]    
Total Debt 13,916 12,719
MTEX Euro Term Loan Due December 21, 2033 [Member]    
Debt Instrument [Line Items]    
Total Debt 1,619 1,514
MTEX Euro Government Grant Term Loan Due January 2027 [Member]    
Debt Instrument [Line Items]    
Total Debt 818 876
Equipment Loan Due January 23, 2029 [Member]    
Debt Instrument [Line Items]    
Total Debt $ 642 $ 680
v3.25.1
Credit Agreement and Long- Term Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Parenthetical) (Detail)
 3 Months Ended 12 Months Ended
Apr. 30, 2025
Jan. 31, 2025
Jan. 31, 2024
Term Loan Due August 4, 2027 [Member]      
Debt Instrument [Line Items]      
Debt instrument, description of variable rate basis USD Term Loan (7.28% as of April 30, 2025 and 6.90% as of January 31, 2025); maturity date of August 4, 2027    
Interest rate 7.28% 6.90%  
Debt instrument, maturity date Aug. 04, 2027 Aug. 04, 2027  
Term Loan Due August 4, 2027 [Member] | Euro [Member]      
Debt Instrument [Line Items]      
Debt instrument, description of variable rate basis Euro Term Loan (5.20% as of April 30, 2025 and 5.38% as of January 31, 2025); maturity date of August 4, 2027    
Interest rate 5.20% 5.38%  
Debt instrument, maturity date Aug. 04, 2027 Aug. 04, 2027  
MTEX Euro Term Loan Due December 21, 2033 [Member]      
Debt Instrument [Line Items]      
Debt instrument, description of variable rate basis MTEX Euro Term Loan (6.022% Fixed Rate); maturity date of December 21, 2033    
Interest rate 6.022% 6.022%  
Debt instrument, maturity date Dec. 21, 2033 Dec. 21, 2033  
MTEX Euro Government Grant Term Loan Due January 2027 [Member]      
Debt Instrument [Line Items]      
Debt instrument, description of variable rate basis MTEX Euro Government Grant Term Loan (0% as of April 30, 2025 and January 31, 2024); maturity dates through January 2027    
Interest rate 0.00%   0.00%
Debt instrument, maturity date Jan. 31, 2027   Jan. 31, 2027
Equipment Loan Due January 23, 2029 [Member]      
Debt Instrument [Line Items]      
Interest rate 7.06% 7.06%  
Debt instrument, maturity date Jan. 23, 2029 Jan. 23, 2029  
v3.25.1
Credit Agreement and Long- Term Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) - Term Loan [Member]
$ in Thousands
Apr. 30, 2025
USD ($)
Debt Instrument [Line Items]  
Fiscal 2026, remainder $ 4,476
Fiscal 2027 6,052
Fiscal 2028 14,214
Fiscal 2029 362
Fiscal 2030 1,016
Long-term Debt $ 26,120
v3.25.1
Financial Instruments and Risk Management - Schedule of Net Investment Hedges (Detail) - Euro Denominated Debt [Member] - Designated as Hedging Instrument [Member] - Net Investment Hedge [Member]
$ in Thousands
 3 Months Ended
Apr. 30, 2025
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]  
Amount of Foreign Currency Translation Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative $ (472)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
v3.25.1
Royalty Obligation - Additional Information (Detail) - USD ($)
 3 Months Ended
Jan. 31, 2018
Apr. 30, 2025
Apr. 27, 2024
Jan. 31, 2025
Guaranteed Minimum Royalty Payments   $ 13,300,000    
Royalty Obligation, Current   1,233,000   $ 1,358,000
Royalty Obligation Non Current   982,000   1,106,000
Accrued Royalties, Current, Excess Royalty Payment Due   580,000   $ 691,000
Honeywell Asset Purchase and License Agreement [Member]        
Payment Term Period 10 years      
Minimum Royalty Payment Obligation $ 15,000,000      
Royalty Obligation, Current   1,000,000    
Royalty Obligation Non Current   700,000    
Excess Royalty Payments   600,000 $ 500,000  
Accrued Royalties, Current, Excess Royalty Payment Due   600,000    
Royalty guarantee commitment amount due current   500,000    
Royalty expense   200,000    
Honeywell Asset Purchase and License Agreement [Member] | Royalty Payments Due Remainder of Fiscal Year [Member]        
Royalty guarantee commitement amount   100,000    
Honeywell Asset Purchase and License Agreement [Member] | Royalty Payments Due In Next Twelve Months [Member]        
Royalty guarantee commitement amount   200,000    
Honeywell Asset Purchase and License Agreement [Member] | Royalty Payments Due Year Two [Member]        
Royalty guarantee commitement amount   233,000    
Honeywell Asset Purchase and License Agreement [Member] | Royalty Payments Due Year Three [Member]        
Royalty guarantee commitement amount   233,000    
Honeywell Asset Purchase and License Agreement [Member] | Royalty Payments Due Year Four [Member]        
Royalty guarantee commitement amount   $ 234,000    
v3.25.1
Leases - Schedule Of Balance Sheet And Other Information Related To Operating Leases (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Operating Leases [Abstract]    
Lease Assets $ 2,763 $ 1,781
Lease Liabilities - Current 528 320
Lease Liabilities - Long Term $ 2,318 $ 1,535
v3.25.1
Leases - Lease Cost Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
General and Administrative Expense [Member]    
Operating Lease Costs $ 158 $ 88
v3.25.1
Leases - Maturities of lease liabilities (Detail)
$ in Thousands
Apr. 30, 2025
USD ($)
Leases [Abstract]  
Fiscal 2026, remaining $ 517
Fiscal 2027 676
Fiscal 2028 614
Fiscal 2029 445
Fiscal 2030 352
Thereafter 832
Total Lease Payments 3,436
Less: Imputed Interest (590)
Total Lease Liabilities $ 2,846
v3.25.1
Leases - Additional Information (Detail)
Apr. 30, 2025
Leases [Abstract]  
Operating Lease, Weighted Average Remaining Lease Term 6 years
Operating Lease, Weighted Average Discount Rate, Percent 6.06%
v3.25.1
Leases - Supplemental cash flow information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Cash paid for amounts included in the measurement of lease liabilities [Abstract]    
Cash paid for operating lease liabilities $ 144 $ 85
v3.25.1
Government Grants - Additional Information (Details)
 3 Months Ended
Apr. 30, 2025
USD ($)
Government Grants [Abstract]  
Short and long-term grant deferred revenue $ 1,400,000
Grant revenue recognized included in depreciation expense 100,000
Grant revenue recognized included in selling and marketing expense 200,000
Contingencies associated with the government grants $ 0
v3.25.1
Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Schedule of Capitalization, Equity [Line Items]    
Beginning Balance $ 75,750 $ 90,282
Other Comprehensive Income 975 (197)
Ending Balance 76,551 $ 91,207
Foreign Currency Translation Adjustments [Member]    
Schedule of Capitalization, Equity [Line Items]    
Beginning Balance (3,349)  
Other Comprehensive Income 975  
Ending Balance $ (2,374)  
v3.25.1
Share-Based Compensation - Additional Information (Detail) - USD ($)
 3 Months Ended
Jun. 11, 2024
Apr. 30, 2025
Apr. 27, 2024
Jan. 31, 2025
Jun. 06, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding   361,549   421,699  
Number of options granted   0 0    
Annual compensation amount   $ 306,000 $ 325,000    
Reservation of shares under Stock Purchase Plan   40,000      
Employee Stock Purchase Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Employee Stock Purchase Plan discount rate   15.00%      
2007 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding   118,449      
2018 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding   130,500      
Shares available for grant under the Plan         600,000
2018 Equity Incentive Plan [Member] | Minimum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares available for grant under the Plan         950,000
2018 Equity Incentive Plan [Member] | Maximum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares available for grant under the Plan         1,550,000
2022 Employee Stock Purchase Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares available for grant under the Plan   6,045      
Prior Employee Stock Purchase Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares purchase under Employee Stock Purchase Plan   6,463      
Stock Options [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense related to options   $ 0      
Restricted Stock Units (RSUs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense to be recognized, Weighted average period   2 years 4 months 24 days      
Unrecognized compensation expense related to RSUs and RSAs   $ 1,900,000      
Restricted Stock Units (RSUs) [Member] | 2018 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of unvested shares   196,147      
RSA [Member] | 2015 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding   112,600      
Performance Based RSUs [Member] | 2018 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of unvested shares   60,615      
Restricted Stock Award [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage of number of shares granted   25.00%      
Annual compensation amount $ 72,800        
v3.25.1
Share-Based Compensation - Share-Based Compensation Expense (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Share-based Compensation [Abstract]    
Stock Options $ 0 $ 0
Restricted Stock Awards and Restricted Stock Units 281 319
Employee Stock Purchase Plan 25 6
Total $ 306 $ 325
v3.25.1
Share-Based Compensation - Aggregated Information Regarding Stock Option Activity (Detail) - $ / shares
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Share-based Compensation [Abstract]    
Beginning balance, Number of Options 421,699  
Granted, Number of Options 0 0
Exercised, Number of Options 0  
Forfeited, Number of Options 0  
Canceled, Number of Options (60,150)  
Ending balance, Number of Options 361,549  
Beginning balance, Weighted-Average Exercise Price $ 15.52  
Granted, Weighted-Average Exercise Price 0  
Exercised, Weighted-Average Exercise Price 0  
Forfeited, Weighted-Average Exercise Price 0  
Cancelled, Weighted-Average Exercise Price 13.95  
Ending balance, Weighted-Average Exercise Price $ 15.78  
v3.25.1
Share-Based Compensation - Summary of Options Outstanding (Detail) - $ / shares
 3 Months Ended
Apr. 30, 2025
Jan. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares outstanding, total 361,549 421,699
Outstanding, Weighted Average Exercise Price $ 15.78  
Outstanding Remaining Contractual Life 1 year 10 months 24 days  
Number of shares exercisable, total 361,549  
Exercisable, Weighted Average Exercise Price $ 15.78  
Exercisable Remaining Contractual Life 1 year 10 months 24 days  
$10.01 - $15.00 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding Range of Exercise prices, Lower Limit $ 10.01  
Outstanding Range of Exercise prices, Upper Limit $ 15  
Outstanding, Number of shares 155,074  
Outstanding, Weighted Average Exercise Price $ 13.61  
Outstanding Remaining Contractual Life 1 year 2 months 12 days  
Exercisable, Number of shares 155,074  
Exercisable, Weighted Average Exercise Price $ 13.61  
Exercisable Remaining Contractual Life 1 year 2 months 12 days  
$15.01 - $20.00 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding Range of Exercise prices, Lower Limit $ 15.01  
Outstanding Range of Exercise prices, Upper Limit $ 20  
Outstanding, Number of shares 206,475  
Outstanding, Weighted Average Exercise Price $ 17.42  
Outstanding Remaining Contractual Life 2 years 4 months 24 days  
Exercisable, Number of shares 206,475  
Exercisable, Weighted Average Exercise Price $ 17.42  
Exercisable Remaining Contractual Life 2 years 4 months 24 days  
v3.25.1
Share-Based Compensation - Aggregated Information Regarding RSU, PSU and RSA Activity (Detail) - Restricted Stock Award Preferred Stock Unit And Restricted Stock Unit [Member]
 3 Months Ended
Apr. 30, 2025
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Beginning balance, Outstanding Restricted Stock Units and Restricted Stock Awards | shares 253,777
Granted, Restricted Stock Units and Restricted Stock Awards | shares 133,773
Vested, Restricted Stock Units and Restricted Stock Awards | shares (65,550)
Forfeited, Restricted Stock Units and Restricted Stock Awards | shares (65,238)
Ending balance, Outstanding Restricted Stock Units and Restricted Stock Awards | shares 256,762
Beginning balance, Weighted Average Grant Date Fair Value | $ / shares $ 14.07
Granted, Weighted Average Grant Date Fair Value | $ / shares 8.23
Vested, Weighted Average Grant Date Fair Value | $ / shares 13.3
Forfeited, Weighted Average Grant Date Fair Value | $ / shares 14.12
Ending balance, Weighted Average Grant Date Fair Value | $ / shares $ 11.21
v3.25.1
Income Taxes - Projected Effective Tax Rates (Detail)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Income Tax Disclosure [Abstract]    
Effective tax rates for income from continuing operations (24.90%) (58.10%)
v3.25.1
Income Taxes - Additional Information (Detail) - USD ($)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Income Tax Disclosure [Abstract]    
Income tax expense (benefit) $ 75,000 $ (434,000)
Effective income tax reconciliation expense related to amended state tax returns 109,000  
Tax expenses benefits resulting from provisional adjustments 62,000 (75,000)
Effective income tax reconciliation tax benefit related to expiration of statute of limitations on previously uncertain tax positions $ (26,000)  
Effective income tax reconciliation benefit related to a previously unrecorded reduction in our future income tax payable balance   $ 572,000
v3.25.1
Segment Information - Additional Information (Detail)
 3 Months Ended
Apr. 30, 2025
Segment
Segment Reporting [Abstract]  
Number of reportable segments 2
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] President and Chief Executive Officer [Member]
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description The CODM evaluates the performance of and allocates resources to the reporting segments based on segment profit or loss, which represents the segments’ income (loss) before income taxes and excludes corporate expenses.
v3.25.1
Segment Information - Net Sales and Segment Operating Profit (Loss) for Each Reporting Segment (Detail) - USD ($)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Segment Reporting Information [Line Items]    
Revenue $ 37,708,000 $ 32,961,000 [1]
General and Administrative Expenses 4,984,000 3,367,000
Operating Income 571,000 1,346,000
Interest Expense (897,000) (482,000)
Other Income (Expense) [2] 25,000 (117,000)
Income (Loss) Before Income Taxes (301,000) 747,000
Income Tax Provision (Benefit) 75,000 (434,000)
Net Income (Loss) (376,000) 1,181,000
Cost of Revenue 25,056,000 20,989,000
Operating Expenses 12,081,000 10,626,000
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Revenue 37,708,000 32,961,000
Operating Income 5,555,000 4,713,000
Cost of Revenue 25,056,000 20,989,000
Operating Expenses 7,097,000 7,259,000
Operating Segments [Member] | Product ID [Member]    
Segment Reporting Information [Line Items]    
Revenue 26,289,000 23,185,000
Operating Income 2,791,000 2,991,000
Cost of Revenue 17,561,000 14,859,000
Operating Expenses [3] 5,937,000 5,335,000
Operating Segments [Member] | Aerospace [Member]    
Segment Reporting Information [Line Items]    
Revenue 11,419,000 9,776,000
Operating Income 2,764,000 1,722,000
Cost of Revenue 7,495,000 6,130,000
Operating Expenses [3] 1,160,000 1,924,000
Corporate Expenses [Member]    
Segment Reporting Information [Line Items]    
General and Administrative Expenses [4] $ (4,984,000) $ (3,367,000)
[1] Certain amounts have been reclassified to conform to the current year's presentation.
[2] Includes gain/(loss) on foreign exchange and other miscellaneous income/(expense) not allocated to the reporting segments.
[3] Product ID and Aerospace segment operating expenses include Selling and Marketing and Research and Development.
[4] The amounts included in Corporate Expenses consist of executive and finance compensation, acquisition and integration costs, restructuring costs, professional fees as well as certain other non-recurring costs not allocated to the reporting segments.
v3.25.1
Segment Information - Summary of Revenue by Product Type (Detail) - USD ($)
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Segment Reporting Information [Line Items]    
Total Revenue $ 37,708,000 $ 32,961,000 [1]
Hardware [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 11,295,000 8,875,000
Supplies [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 21,080,000 18,633,000
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 37,708,000 32,961,000
Operating Segments [Member] | Product ID [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 26,289,000 23,185,000
Operating Segments [Member] | Product ID [Member] | Hardware [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 4,776,000 3,802,000
Operating Segments [Member] | Product ID [Member] | Supplies [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 19,877,000 17,581,000
Operating Segments [Member] | Product ID [Member] | Other [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 1,636,000 1,802,000
Operating Segments [Member] | Aerospace [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 11,419,000 9,776,000
Operating Segments [Member] | Aerospace [Member] | Hardware [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 6,519,000 5,073,000
Operating Segments [Member] | Aerospace [Member] | Supplies [Member]    
Segment Reporting Information [Line Items]    
Total Revenue 1,204,000 1,053,000
Operating Segments [Member] | Aerospace [Member] | Other [Member]    
Segment Reporting Information [Line Items]    
Total Revenue $ 3,696,000 $ 3,650,000
[1] Certain amounts have been reclassified to conform to the current year's presentation.
v3.25.1
Segment Information - Summary of Other Information by Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 27, 2024
Segment Reporting Information [Line Items]    
Depreciation and Amortization $ 1,290 $ 911
Capital Expenditures 60 492
Operating Segments [Member] | Product ID [Member]    
Segment Reporting Information [Line Items]    
Depreciation and Amortization 973 591
Capital Expenditures 60 492
Operating Segments [Member] | Aerospace [Member]    
Segment Reporting Information [Line Items]    
Depreciation and Amortization $ 317 $ 320
v3.25.1
Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) - USD ($)
$ in Thousands
Apr. 30, 2025
Jan. 31, 2025
Fair Value [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-Term debt and related current maturities $ 24,661 $ 25,202
Fair Value [Member] | Level 3 [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-Term debt and related current maturities 24,661 25,202
Carrying Value [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-Term debt and related current maturities $ 26,120 $ 25,239
v3.25.1
Restructuring - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 20, 2025
Apr. 30, 2025
Restructuring Cost and Reserve [Line Items]    
Percentage of reduction of global workforce 10.00%  
Percentage of reduction of product portfolio 70.00%  
Expected annualized cost $ 3,000  
Pre-tax restructuring   $ 558
Other Accrued Expenses [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring liability   500
Product ID Segment Restructuring Plan [Member]    
Restructuring Cost and Reserve [Line Items]    
Pre-tax restructuring   600
Payment of restructuring charge   $ 100
v3.25.1
Restructuring - Summarizes Restructuring Costs (Detail)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
USD ($)
Restructuring Cost and Reserve [Line Items]  
Restructuring Costs $ 558
Cost of Revenue [Member]  
Restructuring Cost and Reserve [Line Items]  
Restructuring Costs 340
Selling & Marketing [Member]  
Restructuring Cost and Reserve [Line Items]  
Restructuring Costs 98
Research & Development [Member]  
Restructuring Cost and Reserve [Line Items]  
Restructuring Costs 0
General & Administrative [Member]  
Restructuring Cost and Reserve [Line Items]  
Restructuring Costs $ 120